﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2017v2.3">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2018-11-13T15:08:42-06:00</ReturnTs>
    <TaxPeriodEndDt>2018-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>560747981</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>DIXON HUGHES GOODMAN LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>440 MONTICELLO AVE SUITE 1400</AddressLine1Txt>
        <CityNm>NORFOLK</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>23510</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2017-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>541806317</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>PATIENT ADVOCATE FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>PATI</BusinessNameControlTxt>
      <PhoneNum>8005325274</PhoneNum>
      <USAddress>
        <AddressLine1Txt>421 BUTLER FARM ROAD</AddressLine1Txt>
        <CityNm>HAMPTON</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>23666</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>ALAN J BALCH</PersonNm>
      <PersonTitleTxt>CHIEF EXECUTIVE OFFICER</PersonTitleTxt>
      <PhoneNum>7578736668</PhoneNum>
      <SignatureDt>2018-11-07</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>CARON E CROUSE</PreparerPersonNm>
      <PTIN>P00630336</PTIN>
      <PhoneNum>7576245100</PhoneNum>
      <PreparationDt>2018-11-06</PreparationDt>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>68.131.13.152</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2018-11-07</IPDt>
      <IPTm>13:44:18</IPTm>
      <IPTimezoneCd>ES</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>DA39A3EE5E6B4B0D3255BFEF95601890AFD80709</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>D070A4E75983FF48FBD4FD3B019D6F149BEFA53A</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2017</TaxYr>
    <BuildTS>2019-02-21 02:37:17Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="12">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>ALAN J BALCH</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>421 BUTLER FARM ROAD</AddressLine1Txt>
        <CityNm>HAMPTON</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>23666</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>378929316</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.PATIENTADVOCATE.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1996</FormationYr>
      <LegalDomicileStateCd>VA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>PATIENT ADVOCATE FOUNDATION (PAF) IS A NATIONAL 501 (C)(3) NON-PROFIT ORGANIZATION THAT PROVIDES PROFESSIONAL CASE MANAGEMENT AND FINANCIAL AID ASSISTANCE TO AMERICANS WITH CHRONIC, LIFE THREATENING AND DEBILITATING ILLNESSES. PAF CASE MANAGERS SERVE AS ACTIVE LIAISONS BETWEEN THE PATIENT AND THEIR INSURER, EMPLOYER AND/OR CREDITORS TO RESOLVE INSURANCE, JOB RETENTION AND/OR DEBT CRISIS MATTERS AS THEY RELATE TO THEIR DIAGNOSIS. PATIENT ADVOCATE FOUNDATION SEEKS TO SAFEGUARD PATIENTS THROUGH EFFECTIVE MEDIATION ASSURING ACCESS TO CARE, MAINTENANCE OF EMPLOYMENT AND PRESERVATION OF THEIR FINANCIAL STABILITY.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>17</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>13</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>246</TotalEmployeeCnt>
      <TotalVolunteersCnt>12</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>218694404</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>368892961</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>5280836</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>6620860</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>1116906</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>3056921</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>7243</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>55331</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>225099389</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>378626073</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>165328885</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>271091655</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>10827517</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>12605037</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>1027731</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>10009227</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>8713198</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>186165629</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>292409890</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>38933760</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>86216183</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>230411429</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>322982588</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>23079550</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>29717694</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>207331879</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>293264894</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>PATIENT ADVOCATE FOUNDATION (PAF) IS A NATIONAL 501 (C)(3) NON-PROFIT ORGANIZATION THAT PROVIDES PROFESSIONAL CASE MANAGEMENT AND FINANCIAL AID SERVICES TO AMERICANS WITH CHRONIC, LIFE THREATENING AND DEBILITATING ILLNESSES. PAF CASE MANAGERS SERVE AS ACTIVE LIAISONS BETWEEN THE PATIENT AND THEIR INSURER, EMPLOYER AND/OR CREDITORS TO RESOLVE INSURANCE, JOB RETENTION AND/OR DEBT CRISIS MATTERS AS THEY RELATE TO THEIR DIAGNOSIS. PATIENT ADVOCATE FOUNDATION SEEKS TO SAFEGUARD PATIENTS THROUGH EFFECTIVE MEDIATION ASSURING ACCESS TO CARE, MAINTENANCE OF EMPLOYMENT AND PRESERVATION OF THEIR FINANCIAL STABILITY.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>278416531</ExpenseAmt>
      <GrantAmt>271049655</GrantAmt>
      <RevenueAmt>0</RevenueAmt>
      <Desc>LAUNCHED IN 2004, THE PATIENT ADVOCATE FOUNDATION'S CO-PAY RELIEF PROGRAM (CPR) PROVIDES FINANCIAL ASSISTANCE WITH CO-PAYMENTS, CO-INSURANCE AND DEDUCTIBLES REQUIRED BY A PATIENT'S INSURER FOR PHARMACEUTICAL TREATMENTS AND/OR PRESCRIPTION MEDICATIONS PRESCRIBED, TO TREAT AND/OR MANAGE THE PATIENT'S DISEASE. THE PROGRAM OFFERS PERSONAL SERVICE TO ALL PATIENTS USING CALL COUNSELORS, PERSONALLY GUIDING PATIENTS THROUGH THE ENROLLMENT AND BENEFIT PROCESS.IN FY2017/2018, PAF'S CO-PAY RELIEF PROGRAM ASSISTED PATIENTS THROUGH TWENTY ONE (25) DISEASE SPECIFIC FUNDS INCLUDING BLADDER CANCER, BREAST CANCER, CERVICAL CANCER, CHRONIC PAIN, ELECTROLYTE IMBALANCE, HEPATITIS B, HEPATITIS C, HIV, AIDS AND PREVENTION, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, INHERITED OR ACQUIRED LIPODYSTROPHY, METASTATIC BREAST CANCER, METASTATIC COLORECTAL CANCER, METASTATIC GASTRIC CANCER, METASTATIC PROSTATE CANCER, MULTIPLE MYELOMA, MULTIPLE SCLEROSIS, MYELODYSPLASTIC SYNDROME, NON-SMALL CELL LUNG CANCERS (NSCLC), OSTEOPOROSIS, OVARIAN CANCER, AND PERIODIC PARALYSIS, PERIPHERAL VASCULAR DISEASE, PROSTATE CANCER, PULMONARY HYPERTENSION &amp; RENAL CELL CARCINOMA.CURRENTLY, THE FOUNDATION'S CO-PAY RELIEF PROGRAM OFFERS A DEDICATED, SECURE WEB-BASED APPLICATION FOR PATIENTS AND/OR THEIR FAMILY MEMBERS TO ENROLL ELECTRONICALLY FOR THE CO-PAY RELIEF PROGRAM DIRECTLY FROM THE CO-PAY RELIEF PROGRAM WEBSITE. AS WELL, CPR OFFERS TWO DEDICATED, SECURED WEBSITES FOR MEDICAL PROVIDERS AND PHARMACY REPRESENTATIVES TO ENROLL ELECTRONICALLY FOR THE CO-PAY RELIEF PROGRAM ON BEHALF OF THE PATIENTS THEY ARE WORKING WITH.IN FY2017/2018, THE FOUNDATION ADMINISTERED CO-PAYMENT ASSISTANCE TO 89,963 QUALIFIED PATIENTS THROUGH THE 25 ASSISTANCE FUNDS AVAILABLE THROUGH THE CO-PAY RELIEF PROGRAM. THE PROGRAM STAFF FIELDED 255,389 TELEPHONE CALLS AND PROCESSED CLAIMS, TOTALING $269,799,000, IN SUPPORT OF QUALIFIED PATIENTS' OUT OF POCKET EXPENSES FOR REQUIRED CO-PAYMENTS, CO-INSURANCE AND DEDUCTIBLES. SINCE ITS INCEPTION IN 2004, THE FOUNDATION HAS PROVIDED CO-PAYMENT ASSISTANCE TO OVER 325,000 INDIVIDUALS ALLOCATING MORE THAN $750 MILLION DOLLARS IN CO-PAYMENT AWARDS.DURING FY2017/2018, PAF ALSO ADMINISTERED SEVEN (7) FINANCIAL AID FUNDS, PROVIDING FINANCIAL ASSISTANCE TO QUALIFIED PATIENTS FOR OUT OF POCKET AND COST OF LIVING EXPENSES FACED BY PATIENTS AS A RESULT OF THEIR DIAGNOSIS AND TREATMENT. IN FY2017/2018, PAF SUCCESSFULLY PROVIDED ONE-TIME SMALL GRANTS TO 2,128 PATIENTS, TOTALING OVER $1,250,250 IN FINANCIAL RELIEF TO QUALIFIED PATIENTS. THE SMALL GRANTS RANGE FROM $300 - $1,000 PER PATIENT AND ARE DESIGNED TO DEFRAY THE COSTS OF TRANSPORTATION AND COST OF LIVING EXPENSES THE PATIENTS FACE. THE FINANCIAL AID FUND PROGRAMS INCLUDE:-LEISHLINE FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH ARDS, TSS AND/OR SEPSIS-METASTATIC BREAST CANCER FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH STAGE III OR STAGE IV BREAST CANCER-MERKEL CELL CARCINOMA FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH A RARE FORM OF SKIN CANCER KNOWN AS MERKEL CELL CARCINOMA-MULTIPLE MYELOMA TRANSPORTATION FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA -TRANSPORTATION FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH METASTATIC MELANOMA OR METASTATIC LUNG CANCER-HEART VALVE FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH A VALVULAR CONDITION-DONNA FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH BREAST CANCER THAT HAVE RECEIVED CASE MANAGEMENT SERVICES THROUGH THE DONNA CARELINE-MAHAN FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>5268447</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>6654188</RevenueAmt>
        <Desc>IN FY2008/2009, THE FOUNDATION ENTERED INTO A TRANSPARENT SERVICE ADMINISTRATION AGREEMENT WITH A NATIONAL NONPROFIT ORGANIZATION. THE FOUNDATION HAS BEEN ENGAGED TO PROVIDE FULL SERVICE, TRANSPARENT ADMINISTRATION SERVICES TO QUALIFIED PATIENTS THAT ENTER THEIR CO-PAY ASSISTANCE PROGRAM. THE FOUNDATION CONTINUED TO PROVIDE THIS CONTRACTUAL SERVICE DURING FY2017/2018 AND WAS PAID ADMINISTRATION FEES MONTHLY THROUGH THIS SERVICE AGREEMENT. THE FOUNDATION ADMINISTERED SERVICES TO 27,610 PATIENTS IN FY2017/2018 THROUGH THIS SERVICE AGREEMENT.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>4889075</ExpenseAmt>
        <GrantAmt>42000</GrantAmt>
        <RevenueAmt>76162</RevenueAmt>
        <Desc>CASE MANAGEMENT SERVICESFOR OVER 20 YEARS, PATIENT ADVOCATE FOUNDATION (PAF) HAS PROVIDED CASE MANAGEMENT INTERVENTION ON BEHALF OF CRITICALLY OR CHRONICALLY ILL PATIENTS NATIONALLY. ENABLING THEM TO CONNECT WITH, AND MAINTAIN ACCESS TO, PRESCRIBED HEALTHCARE SERVICES AND MEDICATIONS, OVERCOME INSURANCE BARRIERS, LOCATE RESOURCES TO SUPPORT COST-OF-LIVING EXPENSES WHILE IN TREATMENT, EVALUATE AND MAINTAIN HEALTH INSURANCE COVERAGE AND BETTER MANAGE, OR REDUCE, THE OUT-OF-POCKET MEDICAL AND COST OF LIVING DEBT THEY FACE. PAF PROVIDES ONE-ON-ONE PROFESSIONAL CASE MANAGEMENT SERVICES, WORKING ALONGSIDE PATIENTS, THEIR LOVED ONES, OR MEDICAL PROFESSIONALS AND OFTEN TAKING THE LEAD TO RESOLVE COMPLEX HEALTHCARE ACCESS AND AFFORDABILITY CHALLENGES ENCOUNTERED IN THE HEALTHCARE SYSTEM. CASE MANAGEMENT SERVICES ARE PROVIDED AT NO COST TO PATIENTS AND THEIR FAMILIES. THE FOUNDATION'S CASE MANAGEMENT STAFF DIRECTLY INTERVENED ON BEHALF OF 24,103 INDIVIDUALS AND CELEBRATED THE PRIVILEGE OF DELIVERING DIRECT ASSISTANCE TO OUR ONE MILLIONTH PATIENT IN FY2017/2018. THESE PATIENTS REPRESENT 490 UNIQUE DISEASES AND REQUESTED ASSISTANCE WITH AN AVERAGE OF TWO ISSUES THAT WERE CREATING OBSTACLES TO CARE. ON AVERAGE, CASE MANAGERS MADE 20 CONTACTS ON BEHALF OF EACH CASE TO RELEVANT STAKEHOLDERS TO BRING RESOLUTION TO THE PATIENT'S ACCESS ISSUES. THIS TRANSLATES TO NEARLY 500,000 UNIQUE CONTACTS ON BEHALF OF PATIENTS AND FAMILIES RECEIVING CASE MANAGEMENT INTERVENTION SERVICES. PAF PROVIDE THESE SERVICES THROUGH A COMPLIMENT OF 20 UNIQUE PROGRAMS.PATIENT EDUCATION &amp; EMPOWERMENTPAF EXTENDS THE IMPACT OF ITS ONE-TO-ONE CASE MANAGEMENT SERVICES THROUGH THE DEVELOPMENT AND DELIVERY OF PATIENT EDUCATION AND EMPOWERMENT TOOLS FOCUSED ON PROVIDING ACTIONABLE ADVICE AND GUIDANCE TO HEALTHCARE CONSUMERS TO IMPROVE THEIR EVERYDAY EXPERIENCE WITH INSURANCE AND TO ENCOURAGE PATIENT'S ENGAGEMENT IN THE HEALTHCARE SYSTEM. PAF'S EDUCATIONAL PORTFOLIO COVERS A BROAD RANGE OF TOPICS, AVAILABLE IN A VARIETY OF FORMATS, TO MEET THE NEEDS AND PREFERENCES OF MULTIPLE AUDIENCES, INCLUDING PATIENTS, CAREGIVERS AND PROFESSIONALS. DURING FY2017/2018, THE FOUNDATION'S PATIENT EDUCATION AND EMPOWERMENT TEAM LAUNCHED A PATIENT INSIGHT AND REVIEWER PANEL CREATING A MECHANISM THROUGH WHICH FEEDBACK AND SUPPORT ON EDUCATIONAL PROJECTS OF ALL KINDS CAN BE OBTAINED IN A SYSTEMATIC AND RELIABLE MANNER, DEVELOPED 15 NEW OR REVISED EDUCATIONAL PUBLICATIONS, LAUNCHED 3 ONLINE EDUCATIONAL TOOLS AND CREATED 10 PATIENT EMPOWERMENT SERIES WEBINARS. THE INFRASTRUCTURE AND CONTENT OF THE NATIONAL FINANCIAL RESOURCE DIRECTORIES, THE MY RESOURCE SEARCH APP, WORDS THAT MATTER VOCABULARY AND GLOSSARY MATERIALS AND CHATTER THAT MATTERS VIDEOS WERE ALSO ENHANCED AND THE CONTENT EXPANDED. HEALTH EQUITY INITIATIVE, COMMUNITY OUTREACH &amp; PATIENT ENGAGEMENTPAF'S HEALTH EQUITY INITIATIVE CONTINUES TO FOCUS ON COMMUNITIES ACROSS THE COUNTRY EXPERIENCING HIGH DISEASE MORTALITY AND/OR DISPARITIES FROM BREAST CANCER AND LUNG CANCER. SPECIFICALLY, EFFORTS CENTER ON LINKING LOCAL STAKEHOLDER ORGANIZATIONS TO THE PLATFORM OF SERVICES AND SUPPORT AVAILABLE THROUGH PAF TO COMPLIMENT LOCAL EDUCATION, EARLY DETECTION, TREATMENT AND SURVIVORSHIP ACTIVITIES. PAF HAS TAKEN AN APPROACH THAT INCLUDES ENGAGEMENT WITH A MYRIAD OF COMMUNITY AND NATIONAL PARTNERS TO ENHANCE THEIR CAPACITY TO FURTHER SUPPORT INDIVIDUALS WITHIN THEIR COMMUNITIES EXPERIENCING BARRIERS TO ACCESSING AND SUSTAINING THE HEALTHCARE THEY NEED. THIS APPROACH HAS RESULTED IN LOCAL AND NATIONAL OPPORTUNITIES TO FURTHER ENHANCE PAF'S INTERFACE WITH LOCAL COMMUNITIES AND CONNECT WITH NATIONAL ORGANIZATIONAL WITH LOCAL CHAPTERS. THROUGH VARIOUS OUTREACH ACTIVITIES, PAF HAS REACHED MORE THAN 2,000 LIMITED RESOURCED INDIVIDUALS OR HEALTHCARE PROVIDERS WHO PROVIDE CARE TO LIMITED RESOURCED POPULATIONS WERE INTRODUCED TO PAF AND THE SERVICES/RESOURCES WE PROVIDE THROUGH THREE (3) NATIONAL AND TEN (10) LOCAL OUTREACH EVENTS.FOR THE FIRST TIME, PAF CONDUCTED AN EDUCATIONAL SESSION AT THE 2017 NATIONAL BLACK NURSES ASSOCIATION ANNUAL CONFERENCE, EDUCATING NURSES FROM AROUND THE COUNTRY ON THE VARIOUS RESOURCES, SERVICES, AND SUPPORT AVAILABLE THROUGH PAF AND HOW TO CONNECT THEIR COMMUNITIES AND THE PATIENTS THEY SERVE TO THESE RESOURCES. FROM THIS PRESENTATION, A NEW PARTNERSHIP WAS FORMED WITH THE NBNA ST. LOUIS CHAPTER, ONE OF 10 CITIES WHERE THE BREAST CANCER MORTALITY DISPARITY FOR AFRICAN-AMERICAN AND CAUCASIAN WOMEN WAS 50% OR GREATER. THROUGH THIS PARTNERSHIP, PAF AND NBNA ST. LOUIS WILL LAUNCH "NURSING BUDDY" A PILOT INITIATIVE TO LINK VOLUNTEER NURSES TO NEWLY DIAGNOSED BREAST CANCER PATIENTS TO EDUCATE THEM ABOUT LOCAL AND NATIONAL RESOURCES, AS WELL AS, SUPPORT NEWLY DIAGNOSED WOMEN WITH BREAST CANCER ALONG THEIR CANCER JOURNEY. IN OCTOBER 2017, THROUGH PAF'S ENGAGEMENT WITH THE MEMPHIS BREAST CANCER CONSORTIUM, PAF PARTICIPATED IN HOSTING MEMPHIS'S INAUGURAL POLICY SERIES ON BREAST CANCER DISPARITIES ENTITLED "LEVELING THE PLAYING FIELD: HOW MBCC CAN SET THE BAR FOR HEALTH EQUITY IN BREAST CARE". THIS EVENT WAS DESIGNED TO BRING AWARENESS TO THE BREAST CANCER DISPARITY ISSUE IN MEMPHIS AND TO ENGAGE NEW STAKEHOLDERS IN IDENTIFYING THEIR ROLE IN FINDING SOLUTIONS. THE PANEL INCLUDED REPRESENTATION FROM THE TENNESSEE BREAST AND CERVICAL CANCER SCREENING PROGRAM, BLUE CROSS/BLUE SHIELD OF TENNESSEE AND THE TRANSPORTATION SECURITY ADMINISTRATION. THE DIVERSITY OF THE PANEL WAS INTENTIONAL TO HIGHLIGHT THE INTERSECTIONALITY OF THESE THREE DISTINCT FUNCTIONS AND THE ROLE THAT EACH OF THEM PLAYS IN IMPACTING AND ULTIMATELY REDUCING BREAST CANCER DISPARITIES. THE FOUNDATION CONTINUES TO EXPAND ITS REACH BEYOND DIRECT PATIENT SERVICES, MAKING AN IMPRESSIVE FOOTPRINT IN POPULATION HEALTH THROUGH THE SELFMADE HEALTH NETWORK (SMHN). THE SMHN IS ONE MEMBER OF THE CDC'S CONSORTIUM OF NATIONAL NETWORKS TO IMPACT POPULATIONS EXPERIENCING TOBACCO-RELATED AND CANCER HEALTH DISPARITIES AND IS SUPPORTED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION OFFICE OF SMOKING ON HEALTH AND THE DIVISION OF CANCER CONTROL AND PREVENTION. THE SMHN FOCUSES ON IMPLEMENTING BEST AND PROMISING PRACTICES TO REDUCE TOBACCO AND CANCER RELATED DISPARITIES AMONG POPULATIONS WITH LOW SOCIOECONOMIC STATUS (SES) CHARACTERISTICS INCLUDING VULNERABLE, UNDERSERVED AND LOW-RESOURCED POPULATIONS) RESIDING IN RURAL, URBAN AND FRONTIER REGIONS. SMHN AND ITS PARTNER, UNIVERSITY OF KENTUCKY SCHOOL OF PUBLIC HEALTH, WERE SELECTED FOR ORAL PRESENTATION AT THE 2017 CDC NATIONAL CANCER CONFERENCE. THE PRESENTATION HIGHLIGHTED INITIAL FINDINGS FROM THE KENTUCKY TOBACCO CESSATION WORKSITE PILOT DESIGNED TO WORK WITH BLUE COLLAR WORKSITES TO BOTH PROMOTE AND ADOPT TOBACCO-FREE POLICIES AND PROVIDE LUNG CANCER EDUCATION AND CESSATION SUPPORT. THE PROJECT HAS ENGAGED WITH LOCAL WORKSITES ACROSS KENTUCKY BENEFITING OVER 1,000 BLUE COLLAR EMPLOYEES. IN ADDITION TO THE NOTED CDC CONFERENCE, SMHN HAD TWO POSTERS SELECTED FOR THE TENTH AACR CONFERENCE ON THE SCIENCE OF CANCER HEALTH DISPARITIES. ONE POSTER HIGHLIGHTED THE AFRICAN-AMERICAN BREAST CANCER WORK LED BY SMHN REGIONAL RESOURCE LEAD ORGANIZATION, MEHARRY MEDICAL COLLEGE AND THE OTHER FEATURED THE KENTUCKY TOBACCO CESSATION WORKSITE PROJECT, LED BY SMHN REGIONAL RESOURCE LEAD ORGANIZATION, UNIVERSITY OF KENTUCKY-SCHOOL OF PUBLIC HEALTH. THE AACR CONFERENCE IS "DESIGNED TO ADVANCE THE UNDERSTANDING AND, ULTIMATELY, HELP TO ELIMINATE THE DISPARITIES IN CANCER THAT REPRESENT A MAJOR PUBLIC HEALTH PROBLEM IN OUR COUNTRY". THE AACR PRESENTATION AFFORDED SMHN THE OPPORTUNITY TO BE AT THE INTERFACE OF ACADEMIA, INDUSTRY, COMMUNITY AND RESEARCH TO MAXIMIZE OPPORTUNITIES TO SPECIFICALLY ADDRESS CANCER DISPARITIES AMONG LOW SES POPULATIONS. IN PARTNERSHIP WITH GEOGRAPHIC HEALTH EQUITY ALLIANCE, SMHN DEVELOPED ITS FIRST FACT SERIES FOR BLUE COLLAR WORKSITE ENTITLED "HEALTHIER NATION". THE SERIES WAS FEATURED IN THE TRUST FOR AMERICA'S HEALTH NEWSLETTER AND DISSEMINATED TO MORE THAN 9,000 SUBSCRIBERS. TWO KEY FUNCTIONS OF THE SMHN ARE THE PROVISION OF TECHNICAL ASSISTANCE (TA) TO STATE CANCER AND TOBACCO PREVENTION AND CONTROL PROGRAM, AND RECOMMENDATIONS TO CDC. OVER THE LAST YEAR, SMHN HAS PROVIDED TA TO STATE CANCER CONTROL PLANS FOR VA, WV AND TX, AND STATE TOBACCO CONTROL PLANS FOR NE, IL, AND MA. SPECIFICALLY, SMHN CO-DEVELOPED THE DISPARITIES SECTION OF THE VIRGINIA DEPARTMENT OF HEALTH'S 2018-2022 STATE CANCER PLAN. ADDITIONALLY, SMHN PROVIDED GUIDANCE TO THE CDC DIVISION OF CANCER PREVENTION AND CONTROL IN THE DEVELOPMENT OF WHAT WILL BE THE FIRST NATIONAL NETWORKS SNAPSHOT DOCUMENT. CONTINUED LATER IN SCHEDULE O</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>288574053</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="RetDoc1039600001">0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="RetDoc1039600001">1</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="RetDoc1039600001">0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">1</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc1041300001">0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc1041300001">1</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc1041300001">0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043400001">0</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043400001">1</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043400001">1</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>12</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>246</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>1</NondeductibleContributionsInd>
      <NondeductibleContriDisclInd>1</NondeductibleContriDisclInd>
      <QuidProQuoContributionsInd>1</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>1</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>17</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>13</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>CORPORATE OFFICE</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>7578736668</PhoneNum>
        <USAddress>
          <AddressLine1Txt>421 BUTLER FARM ROAD</AddressLine1Txt>
          <CityNm>HAMPTON</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>23666</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEBORAH PARHAM HOPSON</PersonNm>
        <TitleTxt>BOARD PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALAN J BALCH</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>20.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>20.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>186611</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>125000</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>10800</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>F MARC STEWART</PersonNm>
        <TitleTxt>BOARD MEMBER, IMMEDIATE PA</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NANCY DAVENPORT-ENNIS</PersonNm>
        <TitleTxt>FOUNDER AND CHAIR EMERITA</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DIANE MAUK</PersonNm>
        <TitleTxt>BOARD SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN L MURPHY</PersonNm>
        <TitleTxt>FINANCE COMMITTEE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>AL BENSON III</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHRISTIAN G DOWNS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN H ENNIS</PersonNm>
        <TitleTxt>CO-FOUNDER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BRIAN GAROFALO</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>OTIS MAYNARD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANDY MILLER</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>EDITH MITCHELL</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PEARL MOORE</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROBERT M RIFKIN</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LORI WILLIAMS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>W JACKSON WISDOM</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WILLIAM J NASON</PersonNm>
        <TitleTxt>CHIEF FINANCIAL OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>205716</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>23729</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>FRANCES CASTELLOW</PersonNm>
        <TitleTxt>PRESIDENT OF OPERATIONS</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>209478</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>8127</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANGELA M WALKER</PersonNm>
        <TitleTxt>CHIEF OF TALENT MANAGEMENT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>166265</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>6378</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ERIN SINGLETON</PersonNm>
        <TitleTxt>CHIEF OF MISSION DELIVERY</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>147377</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>10798</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALAN RICHARDSON</PersonNm>
        <TitleTxt>EVP OF STRATEGIC PATIENT S</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>145667</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>20734</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SAKHTI CHOKKALINGAM</PersonNm>
        <TitleTxt>SENIOR PEGA SYSTEMS ARCHIT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>158154</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>19735</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SHONTA CHAMBERS</PersonNm>
        <TitleTxt>EVP OF HEALTH EQUITY INITIATIVES</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>146012</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>21963</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>1365280</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>125000</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>122264</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>15</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>FIPSAR INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>424 COURTYARD DRIVE</AddressLine1Txt>
            <CityNm>HILLSBOROUGH</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>08844</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>CONSULTING/SOFTWARE</ServicesDesc>
        <CompensationAmt>1010663</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>ANTHEM BCBS</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 580494</AddressLine1Txt>
            <CityNm>CHARLOTTE</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>28258</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>HEALTH INSURANCE VENDOR</ServicesDesc>
        <CompensationAmt>1009892</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>INCONTACT INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 410468</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84141</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MANAGES PHONE SYSTEM</ServicesDesc>
        <CompensationAmt>707511</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>WACHOVIA SECURITIES LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>11817 CANON BLVD SUITE 100</AddressLine1Txt>
            <CityNm>NEWPORT NEWS</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>23606</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MANAGES 401K</ServicesDesc>
        <CompensationAmt>283791</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>EASYLINK SERVICESOPENTEXT</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>2950 S DELAWARE STREET BAY MEADOWS</AddressLine1Txt>
            <CityNm>SAN MATEO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94403</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>ELECTRONIC MESSAGING AND BUSINESS INTEGR</ServicesDesc>
        <CompensationAmt>185249</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>12</CntrctRcvdGreaterThan100KCnt>
      <MembershipDuesAmt>150000</MembershipDuesAmt>
      <FundraisingAmt>192624</FundraisingAmt>
      <GovernmentGrantsAmt>507802</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>368042535</AllOtherContributionsAmt>
      <NoncashContributionsAmt>38374</NoncashContributionsAmt>
      <TotalContributionsAmt>368892961</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>SERVICE CONTRACTS</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>6620860</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>6620860</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>6620860</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>2946894</TotalRevenueColumnAmt>
        <ExclusionAmt>2946894</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>185000</SecuritiesAmt>
        <OtherAmt>133743</OtherAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>184463</SecuritiesAmt>
        <OtherAmt>24253</OtherAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>537</SecuritiesAmt>
        <OtherAmt>109490</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>110027</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>109490</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>537</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>149858</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>192624</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>94527</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>55331</TotalRevenueColumnAmt>
        <ExclusionAmt>55331</ExclusionAmt>
      </NetIncmFromFundraisingEvtGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>378626073</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>6730350</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>3002762</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>271091655</TotalAmt>
        <ProgramServicesAmt>271091655</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>680510</TotalAmt>
        <ProgramServicesAmt>293668</ProgramServicesAmt>
        <ManagementAndGeneralAmt>285096</ManagementAndGeneralAmt>
        <FundraisingAmt>101746</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>9952557</TotalAmt>
        <ProgramServicesAmt>8748884</ProgramServicesAmt>
        <ManagementAndGeneralAmt>591928</ManagementAndGeneralAmt>
        <FundraisingAmt>611745</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>258286</TotalAmt>
        <ProgramServicesAmt>148235</ProgramServicesAmt>
        <ManagementAndGeneralAmt>88203</ManagementAndGeneralAmt>
        <FundraisingAmt>21848</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>1009135</TotalAmt>
        <ProgramServicesAmt>857325</ProgramServicesAmt>
        <ManagementAndGeneralAmt>88818</ManagementAndGeneralAmt>
        <FundraisingAmt>62992</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>704549</TotalAmt>
        <ProgramServicesAmt>596402</ProgramServicesAmt>
        <ManagementAndGeneralAmt>57255</ManagementAndGeneralAmt>
        <FundraisingAmt>50892</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>359644</TotalAmt>
        <ProgramServicesAmt>144333</ProgramServicesAmt>
        <ManagementAndGeneralAmt>215311</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>144657</TotalAmt>
        <ProgramServicesAmt>16000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>128657</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>780000</TotalAmt>
        <ManagementAndGeneralAmt>780000</ManagementAndGeneralAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>1400860</TotalAmt>
        <ProgramServicesAmt>1321913</ProgramServicesAmt>
        <ManagementAndGeneralAmt>78947</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>2849947</TotalAmt>
        <ProgramServicesAmt>2502218</ProgramServicesAmt>
        <ManagementAndGeneralAmt>302374</ManagementAndGeneralAmt>
        <FundraisingAmt>45355</FundraisingAmt>
      </OfficeExpensesGrp>
      <OccupancyGrp>
        <TotalAmt>719167</TotalAmt>
        <ProgramServicesAmt>661921</ProgramServicesAmt>
        <ManagementAndGeneralAmt>33082</ManagementAndGeneralAmt>
        <FundraisingAmt>24164</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>185301</TotalAmt>
        <ProgramServicesAmt>70741</ProgramServicesAmt>
        <ManagementAndGeneralAmt>18394</ManagementAndGeneralAmt>
        <FundraisingAmt>96166</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>502800</TotalAmt>
        <ProgramServicesAmt>469522</ProgramServicesAmt>
        <ManagementAndGeneralAmt>33278</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>108384</TotalAmt>
        <ProgramServicesAmt>107036</ProgramServicesAmt>
        <ManagementAndGeneralAmt>297</ManagementAndGeneralAmt>
        <FundraisingAmt>1051</FundraisingAmt>
      </InterestGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>1564158</TotalAmt>
        <ProgramServicesAmt>1532804</ProgramServicesAmt>
        <ManagementAndGeneralAmt>19998</ManagementAndGeneralAmt>
        <FundraisingAmt>11356</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>98280</TotalAmt>
        <ProgramServicesAmt>11396</ProgramServicesAmt>
        <ManagementAndGeneralAmt>86468</ManagementAndGeneralAmt>
        <FundraisingAmt>416</FundraisingAmt>
      </InsuranceGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>292409890</TotalAmt>
        <ProgramServicesAmt>288574053</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2808106</ManagementAndGeneralAmt>
        <FundraisingAmt>1027731</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>18676495</BOYAmt>
        <EOYAmt>24050994</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>202912026</BOYAmt>
        <EOYAmt>261254275</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>450813</BOYAmt>
        <EOYAmt>30424481</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>663881</BOYAmt>
        <EOYAmt>521604</EOYAmt>
      </AccountsReceivableGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>27249</BOYAmt>
        <EOYAmt>58570</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>591597</BOYAmt>
        <EOYAmt>405146</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>9513986</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>5295814</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>5042401</BOYAmt>
        <EOYAmt>4218172</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>1996636</BOYAmt>
        <EOYAmt>1999015</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>50331</BOYAmt>
        <EOYAmt>50331</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>230411429</BOYAmt>
        <EOYAmt>322982588</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>4220674</BOYAmt>
        <EOYAmt>8650706</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>16448938</BOYAmt>
        <EOYAmt>18203925</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>2409938</BOYAmt>
        <EOYAmt>2863063</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>23079550</BOYAmt>
        <EOYAmt>29717694</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>7419535</BOYAmt>
        <EOYAmt>11556465</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>199912344</BOYAmt>
        <EOYAmt>281708429</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>207331879</BOYAmt>
        <EOYAmt>293264894</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>230411429</BOYAmt>
        <EOYAmt>322982588</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>86216183</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-27664</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>-255504</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>1</FederalGrantAuditRequiredInd>
      <FederalGrantAuditPerformedInd>1</FederalGrantAuditPerformedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>35867506</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>59477193</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>92569903</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>183610619</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>368892961</CurrentTaxYearAmt>
        <TotalAmt>740418182</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>35867506</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>59477193</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>92569903</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>183610619</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>368892961</CurrentTaxYearAmt>
        <TotalAmt>740418182</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>562669032</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>177749150</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>258390</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>402970</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>713599</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1145492</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2946894</CurrentTaxYearAmt>
        <TotalAmt>5467345</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>745885527</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>25023956</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.23830</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.27720</PublicSupportPY170Pct>
      <TenPctFactsCrcmstncsTestCYInd>X</TenPctFactsCrcmstncsTestCYInd>
      <FactsAndCircumstancesTestTxt>PATIENT ADVOCATE FOUNDATION OFFERS THE FOLLOWING FACTS AND CIRCUMSTANCES IN SUPPORT OF ITS ONGOING CLASSIFICATIONS AS A PUBLIC CHARITY AS DEFINED IN SECTION 170(B) (1) (A). ORGANIZATION BACKGROUND &amp; PROGRAM INFORMATIONPATIENT ADVOCATE FOUNDATION (FOUNDATION OR PAF) IS A 501(C) 3 NATIONAL NONPROFIT ORGANIZATION THAT IS ORGANIZED TO SAFEGUARD PATIENTS THROUGH EFFECTIVE MEDIATION ASSURING ACCESS TO CARE, MAINTENANCE OF EMPLOYMENT AND PRESERVATION OF FINANCIAL STABILITY RELATIVE TO THEIR DIAGNOSIS OF LIFE THREATENING OR DEBILITATING DISEASES. THE FOUNDATION HAS DEVELOPED AND DELIVERS A DIVERSE PORTFOLIO OF PATIENT CENTERED PROGRAMS TO PATIENTS AND THEIR FAMILIES INCLUDING IN DEPTH CASE MANAGEMENT SERVICES, SMALL GRANT PROGRAMS THAT PROVIDE SUPPORT FOR COST OF LIVING EXPENSES FOR LOW INCOME PATIENTS, AND PATIENT EDUCATIONAL PROGRAMS DELIVERED IN PRINT, DIGITAL AND ONLINE INTERACTIVE FORMATS. THE FOUNDATION ALSO ADMINISTERS THE CO-PAY RELIEF PROGRAM (CPR) THAT PROVIDES FINANCIAL SUPPORT FOR CO-PAYMENTS AND COINSURANCE REQUIRED FOR PHARMACEUTICAL TREATMENTS PRESCRIBED TO TREAT AND/OR MANAGE CERTAIN CHRONIC AND LIFE-THREATENING CONDITIONS. THROUGH THE FOUNDATION'S COMPLIMENT OF CASE MANAGEMENT, FINANCIAL ASSISTANCE AND EDUCATIONAL PROGRAMS, THE FOUNDATION ASSISTS TENS OF THOUSANDS OF PATIENTS LIVING THROUGHOUT THE UNITED STATES AND US TERRITORIES EVERY YEAR. PAF SERVED NEARLY 144,000 PATIENTS IN FY2017/2018 AND HAS PROVIDED HELP AND ASSISTANCE TO OVER ONE MILLION PATIENTS AND FAMILIES SINCE ITS INCEPTION IN 1996. PAF IS PUBLICLY SUPPORTED, PRIMARILY RECEIVING IT'S SUPPORT THROUGH CHARITABLE CONTRIBUTIONS, GRANTS, COOPERATIVE AGREEMENTS WITH GOVERNMENTAL AGENCIES AND OTHER 501(C)3 NON-PROFIT ORGANIZATIONS AND DONATIONS FROM THE GENERAL PUBLIC, THUS, ALLOWING PAF TO OFFER ITS DIVERSE PROGRAMMING TO PATIENTS COMPLETELY FREE OF CHARGE.CASE MANAGEMENT &amp; FINANCIAL SUPPORT PROGRAMSFOR OVER 20 YEARS, PATIENT ADVOCATE FOUNDATION (PAF) HAS PROVIDED CASE MANAGEMENT INTERVENTION ON BEHALF OF CRITICALLY OR CHRONICALLY ILL PATIENTS NATIONALLY. ENABLING THEM TO CONNECT WITH, AND MAINTAIN ACCESS TO, PRESCRIBED HEALTHCARE SERVICES AND MEDICATIONS, OVERCOME INSURANCE BARRIERS, LOCATE RESOURCES TO SUPPORT COST-OF-LIVING EXPENSES WHILE IN TREATMENT, EVALUATE AND MAINTAIN HEALTH INSURANCE COVERAGE AND BETTER MANAGE, OR REDUCE, THE OUT-OF-POCKET MEDICAL AND COST OF LIVING DEBT THEY FACE. PAF PROVIDES ONE-ON-ONE PROFESSIONAL CASE MANAGEMENT SERVICES, WORKING ALONGSIDE PATIENTS, THEIR LOVED ONES, OR MEDICAL PROFESSIONALS AND OFTEN TAKING THE LEAD TO RESOLVE COMPLEX HEALTHCARE ACCESS AND AFFORDABILITY CHALLENGES ENCOUNTERED IN THE HEALTHCARE SYSTEM. CASE MANAGEMENT SERVICES ARE PROVIDED AT NO COST TO PATIENTS AND THEIR FAMILIES. THE FOUNDATION'S CASE MANAGEMENT STAFF DIRECTLY INTERVENED ON BEHALF OF 24,103 INDIVIDUALS AND CELEBRATED THE PRIVILEGE OF DELIVERING DIRECT ASSISTANCE TO OUR ONE MILLIONTH PATIENT IN FY2017/2018. THESE PATIENTS REPRESENT 490 UNIQUE DISEASES AND REQUESTED ASSISTANCE WITH AN AVERAGE OF TWO ISSUES THAT WERE CREATING OBSTACLES TO CARE. ON AVERAGE, CASE MANAGERS MADE 20 CONTACTS ON BEHALF OF EACH CASE TO RELEVANT STAKEHOLDERS TO BRING RESOLUTION TO THE PATIENT'S ACCESS ISSUES. THIS TRANSLATES TO NEARLY 500,000 UNIQUE CONTACTS ON BEHALF OF PATIENTS AND FAMILIES RECEIVING CASE MANAGEMENT INTERVENTION SERVICES. PAF PROVIDE THESE SERVICES THROUGH A COMPLIMENT OF 20 UNIQUE PROGRAMS.DURING FY2017/2018, PAF ADMINISTERED A SUITE OF SEVEN SMALL GRANT PROGRAMS, REFERRED TO AS FINANCIAL AID FUNDS, EACH OF WHICH PROVIDE FINANCIAL ASSISTANCE TO QUALIFIED PATIENTS FOR PRACTICAL COST OF LIVING EXPENSES, INCLUDING TRANSPORTATION EXPENSES, FACED BY THESE PATIENTS. IN FY2017/2018, PAF SUCCESSFULLY PROVIDED ONE-TIME SMALL GRANTS TO 2,128 PATIENTS, TOTALING OVER $1,250,250 IN FINANCIAL RELIEF TO QUALIFIED PATIENTS. THE SMALL GRANTS RANGE FROM $300-$1000 PER PATIENT AND ARE DESIGNED TO DEFRAY THE OUT OF POCKET AND COST OF LIVING EXPENSES, INCLUDING TRANSPORTATION, LODGING, NUTRITIONAL NEEDS, CHILD CARE AND BURIAL EXPENSES, FACED BY PATIENTS AS A RESULT OF THEIR DIAGNOSIS AND TREATMENT. THE FINANCIAL AID FUND PROGRAMS INCLUDE: DONNA FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH BREAST CANCER THAT HAVE RECEIVED CASE MANAGEMENT SERVICES THROUGH THE DONNA CARELINE HEART VALVE FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH A VALVULAR CONDITION LEISHLINE FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH ARDS, TSS AND/OR SEPSIS MAHAN FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA MERKEL CELL CARCINOMA FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH A RARE FORM OF SKIN CANCER METASTATIC BREAST CANCER FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH STAGE III OR STAGE IV BREAST CANCER MULTIPLE MYELOMA TRANSPORTATION FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA TRANSPORTATION FINANCIAL AID FUND: SERVING PATIENTS DIAGNOSED WITH METASTATIC MELANOMA OR METASTATIC LUNG CANCERLAUNCHED IN 2004 IN RESPONSE TO A CRITICAL MASS OF PATIENTS REPORTING THEIR NEED FOR SUPPORT WITH UNMANAGEABLE CO-PAYMENTS FOR LIFE SAVING MEDICINES, PATIENT ADVOCATE FOUNDATION'S CO-PAY RELIEF PROGRAM (CPR) PROVIDES NEEDS-BASED FINANCIAL ASSISTANCE WITH CO-PAYMENTS, CO-INSURANCE AND DEDUCTIBLES REQUIRED BY A PATIENT'S INSURER FOR PHARMACEUTICAL TREATMENTS AND/OR PRESCRIPTION MEDICATIONS PRESCRIBED, TO TREAT AND/OR MANAGE THE PATIENT'S DISEASE. TO QUALIFY FOR A GIVEN DISEASE-SPECIFIC FUND, AN APPLICANT MUST (1) HAVE A CONFIRMED DIAGNOSIS THAT IS SUPPORTED BY THE DISEASE FUND, (2) HAVE A TREATMENT REGIMEN IN PLACE, (3) HAVE AND MAINTAIN HEALTH INSURANCE AND (4) MEET THE FINANCIAL CRITERIA SET FORTH BY CPR FOR THE FUND. THE PROGRAM OFFERS PERSONAL SERVICE TO ALL PATIENTS USING CALL COUNSELORS; PERSONALLY, GUIDING PATIENTS THROUGH THE ENROLLMENT AND BENEFIT PROCESS.PAF WILL NOT CONSIDER THE IDENTITY OF ANY PHYSICIAN, PROVIDER, SUPPLIER OF ITEMS OR SERVICES, DONOR, DRUG THERAPY, SERVICES OR SUPPLIES BEING UTILIZED OR THE REFERRAL SOURCE WHEN ASSESSING WHETHER AN APPLICANT IS QUALIFIED FOR FINANCIAL ASSISTANCE FROM A PAF CPR DISEASE-SPECIFIC FUND. UNDER NO CIRCUMSTANCES WILL PAF RECOMMEND OR REFER AN APPLICANT OR ENROLLEE TO ANY FUND DONOR, PROVIDER, SUPPLIER OR PRODUCT.QUALIFYING APPLICANTS ARE ENROLLED IN A DISEASE-SPECIFIC FUND FOR UP TO ONE YEAR FROM THE DATE OF ENROLLMENT AND MUST RE-APPLY THEREAFTER TO CONTINUE RECEIVING ASSISTANCE FROM A GIVEN DISEASE-SPECIFIC FUND. ENROLLMENT IN AND FINANCIAL ASSISTANCE FROM ANY DISEASE-SPECIFIC FUND IS PROVIDED ON A FIRST COME, FIRST SERVE BASIS TO THE EXTENT FUNDING IS AND REMAINS AVAILABLE.FINANCIAL ASSISTANCE FROM ANY CPR DISEASE-SPECIFIC FUND IS NOT DEPENDENT ON THE USE A PARTICULAR DRUG OR PROVIDER AND ENROLLEES ARE FREE TO SWITCH DRUG THERAPIES, TREATING PHYSICIANS, PHARMACIES AND SUPPLIERS AT ANY TIME WITHOUT AFFECTING THEIR CONTINUED ELIGIBILITY FOR FINANCIAL ASSISTANCE FROM A DISEASE-SPECIFIC FUND.ENROLLEES ARE REQUIRED TO INFORM PAF IN THE EVENT THEIR FINANCIAL CIRCUMSTANCES CHANGE, AND/OR THEY LOSE THEIR HEALTH INSURANCE COVERAGE DURING THEIR ENROLLMENT PERIOD AS SUCH CHANGES MAY AFFECT ENROLLEE ELIGIBILITY FOR A GIVEN CPR FUND.IN FY2017/2018, PAF'S CO-PAY RELIEF PROGRAM EXPANDED ITS PROGRAM IMPACT THROUGH THE ADDITION OF FOUR NEW FUNDS, ASSISTING PATIENTS THROUGH TWENTY-FIVE (25) DISEASE SPECIFIC FUNDS INCLUDING BLADDER CANCER, BREAST CANCER, CERVICAL CANCER, CHRONIC PAIN, ELECTROLYTE IMBALANCE, HEPATITIS B, HEPATITIS C, HIV, AIDS AND PREVENTION, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, INHERITED OR ACQUIRED LIPODYSTROPHY, METASTATIC BREAST CANCER, METASTATIC COLORECTAL CANCER, METASTATIC GASTRIC CANCER, METASTATIC PROSTATE CANCER, MULTIPLE MYELOMA, MULTIPLE SCLEROSIS, MYELODYSPLASTIC SYNDROME, NON-SMALL CELL LUNG CANCERS (NSCLC), OSTEOPOROSIS, OVARIAN CANCER, AND PERIODIC PARALYSIS, PERIPHERAL VASCULAR DISEASE, PROSTATE CANCER, PULMONARY HYPERTENSION &amp; RENAL CELL CARCINOMA. THE FOUNDATION'S CO-PAY RELIEF PROGRAM OFFERS A DEDICATED, SECURE WEB-BASED APPLICATION FOR PATIENTS AND/OR THEIR FAMILY MEMBERS TO ENROLL ELECTRONICALLY FOR THE CO-PAY RELIEF PROGRAM DIRECTLY FROM THE CO-PAY RELIEF PROGRAM WEBSITE. AS WELL, CPR OFFERS TWO DEDICATED, SECURED WEBSITES FOR MEDICAL PROVIDERS AND PHARMACY REPRESENTATIVES TO ENROLL ELECTRONICALLY FOR THE CO-PAY RELIEF PROGRAM ON BEHALF OF THE PATIENTS THEY ARE WORKING WITH.SEE CONTINUATION IN SCHEDULE O.</FactsAndCircumstancesTestTxt>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001" />
    <IRS990ScheduleC documentId="RetDoc1039600001">
      <TotalDirectLobbyingGrp>
        <FilingOrganizationsTotalAmt>780000</FilingOrganizationsTotalAmt>
      </TotalDirectLobbyingGrp>
      <TotalLobbyingExpendGrp>
        <FilingOrganizationsTotalAmt>780000</FilingOrganizationsTotalAmt>
      </TotalLobbyingExpendGrp>
      <OtherExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>291629890</FilingOrganizationsTotalAmt>
      </OtherExemptPurposeExpendGrp>
      <TotalExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>292409890</FilingOrganizationsTotalAmt>
      </TotalExemptPurposeExpendGrp>
      <LobbyingNontaxableAmountGrp>
        <FilingOrganizationsTotalAmt>1000000</FilingOrganizationsTotalAmt>
      </LobbyingNontaxableAmountGrp>
      <GrassrootsNontaxableGrp>
        <FilingOrganizationsTotalAmt>250000</FilingOrganizationsTotalAmt>
      </GrassrootsNontaxableGrp>
      <TotLbbyngGrassrootMnsNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyngGrassrootMnsNonTxGrp>
      <TotLbbyExpendMnsLbbyngNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyExpendMnsLbbyngNonTxGrp>
      <AvgLobbyingNontaxableAmountGrp>
        <CurrentYearMinus3Amt>1000000</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>1000000</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>1000000</CurrentYearMinus1Amt>
        <CurrentYearAmt>1000000</CurrentYearAmt>
        <TotalAmt>4000000</TotalAmt>
      </AvgLobbyingNontaxableAmountGrp>
      <LobbyingCeilingAmt>6000000</LobbyingCeilingAmt>
      <AvgTotalLobbyingExpendGrp>
        <CurrentYearMinus3Amt>880000</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>700000</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>720000</CurrentYearMinus1Amt>
        <CurrentYearAmt>780000</CurrentYearAmt>
        <TotalAmt>3080000</TotalAmt>
      </AvgTotalLobbyingExpendGrp>
      <AvgGrassrootsNontaxableGrp>
        <CurrentYearMinus3Amt>250000</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>250000</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>250000</CurrentYearMinus1Amt>
        <CurrentYearAmt>250000</CurrentYearAmt>
        <TotalAmt>1000000</TotalAmt>
      </AvgGrassrootsNontaxableGrp>
      <GrassrootsCeilingAmt>1500000</GrassrootsCeilingAmt>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>1996636</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>2379</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>1999015</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>1486242</BeginningYearBalanceAmt>
        <ContributionsAmt>512115</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-1721</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>1996636</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>1933371</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>64986</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>512115</OtherExpendituresAmt>
        <EndYearBalanceAmt>1486242</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>1909422</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>23949</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>1933371</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>1846290</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>63132</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>1909422</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>1.00000</BoardDesignatedBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>84697</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>15661</DepreciationAmt>
        <BookValueAmt>69036</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>9084619</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>5280153</DepreciationAmt>
        <BookValueAmt>3804466</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>344670</OtherCostOrOtherBasisAmt>
        <BookValueAmt>344670</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>4218172</TotalBookValueLandBuildingsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>ACCRUED VACATION</Desc>
        <Amt>318690</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>IBNR RESERVE</Desc>
        <Amt>92974</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>POSTRETIREMENT LIABILITY</Desc>
        <Amt>2451399</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>2863063</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>378585446</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-27664</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>2000</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>-25664</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>378611110</RevenueSubtotalAmt>
      <OtherRevenuesNotIncludedAmt>14963</OtherRevenuesNotIncludedAmt>
      <RevenueNotReportedFinclStmtAmt>14963</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>378626073</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>292396927</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>2000</DonatedServicesUseFcltsAmt>
      <OtherExpensesIncludedAmt>-14963</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>-12963</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>292409890</ExpensesSubtotalAmt>
      <ExpensesNotRptFinclStmtAmt>0</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>292409890</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ENDOWMENT FUND OF PATIENT ADVOCATE FOUNDATION WAS ESTABLISHED IN 2001 TO FURTHER ITS EXEMPT PURPOSE BY SUPPORTING DIRECT PATIENT SERVICES. THE ENDOWMENT FUND BUILDS LONG-TERM STABILITY FOR THE FUTURE OF THE FOUNDATION BY PROVIDING AN ADDITIONAL SOURCE OF INCOME TO MEET AN INCREASING DEMAND FOR NATIONAL PROGRAMS AND SERVICES. IT PROVIDES FOR INTEREST INCOME TO BE USED BY PAF AND RESTRICTS ACCESS TO PRINCIPAL BASED UPON BOARD APPROVAL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND THE COMMONWEALTH OF VIRGINIA STATUTES; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XI, LINE 4B - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECT EXPENSES FOR FUNDRAISING EVENT -94,527. GAIN ON FIXED ASSETS INCLUDED IN EXPENSES FOR F/S 109,490.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECT EXPENSES FOR FUNDRAISING EVENT 94,527. GAIN ON FIXED ASSET INCLUDED IN EXPENSES FOR F/S -109,490.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc1041300001">
      <FundraisingEventInformationGrp>
        <Event1Nm>PROMISE OF HOPE</Event1Nm>
        <GrossReceiptsEvent1Amt>342482</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>192624</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>149858</GrossRevenueEvent1Amt>
        <NonCashPrizesEvent1Amt>38374</NonCashPrizesEvent1Amt>
        <RentFacilityCostsEvent1Amt>8174</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>30988</FoodAndBeverageEvent1Amt>
        <EntertainmentEvent1Amt>300</EntertainmentEvent1Amt>
        <OtherDirectExpensesEvent1Amt>16691</OtherDirectExpensesEvent1Amt>
        <GrossReceiptsTotalAmt>342482</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>192624</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>149858</GrossRevenueTotalEventsAmt>
        <NonCashPrizesTotalEventsAmt>38374</NonCashPrizesTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>8174</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>30988</FoodAndBeverageTotalEventsAmt>
        <EntertainmentTotalEventsAmt>300</EntertainmentTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>16691</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>94527</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>55331</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>SCHOLARSHIPS</GrantTypeTxt>
        <RecipientCnt>12</RecipientCnt>
        <CashGrantAmt>42000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>CO PAY RELIEF ASSISTANCE</GrantTypeTxt>
        <RecipientCnt>89963</RecipientCnt>
        <CashGrantAmt>271049655</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THROUGH PATIENT ADVOCATE FOUNDATIONS SCHOLARSHIP FOR SURVIVORS, 12 SCHOLARSHIPS WERE AWARDED TO STUDENTS WHOSE STUDIES WERE INTERRUPTED OR DELAYED BY A DIAGNOSIS OF A LIFE THREATENING, CHRONIC OR DEBILITATING DISEASE. THE STUDENTS MUST BE ENROLLED FULL-TIME, MAINTAINING GPA OF 3.0 OR BETTER AND COMPLETE 20 HOURS OF COMMUNITY SERVICE DURING THE ACADEMIC YEAR. PATIENT ADVOCATE FOUNDATION (PAF) CO-PAY RELIEF PROGRAM (CPR) CURRENTLY PROVIDES DIRECT FINANCIAL SUPPORT TO INSURED PATIENTS WHO MUST FINANCIALLY AND MEDICALLY QUALIFY TO ACCESS PHARMACEUTICAL CO-PAYMENT ASSISTANCE. THE PROGRAM OFFERS PERSONAL SERVICE TO ALL PATIENTS THROUGH THE USE OF CALL COUNSELORS; PERSONALLY GUIDING PATIENTS THROUGH THE ENROLLMENT PROCESS. IN FY2017/2018, PAF'S CO-PAY RELIEF PROGRAM ASSISTED PATIENTS THROUGH TWENTY-FIVE (25) DISEASE SPECIFIC FUNDS INCLUDING BLADDER CANCER, BREAST CANCER, CERVICAL CANCER, CHRONIC PAIN, ELECTROLYTE IMBALANCE, HEPATITIS B, HEPATITIS C, HIV, AIDS AND PREVENTION, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, INHERITED OR ACQUIRED LIPODYSTROPHY, METASTATIC BREAST CANCER, METASTATIC COLORECTAL CANCER, METASTATIC GASTRIC CANCER, METASTATIC PROSTATE CANCER, MULTIPLE MYELOMA, MULTIPLE SCLEROSIS, MYELODYSPLASTIC SYNDROME, NON-SMALL CELL LUNG CANCERS (NSCLC), OSTEOPOROSIS, OVARIAN CANCER, AND PERIODIC PARALYSIS, PERIPHERAL VASCULAR DISEASE, PROSTATE CANCER, PULMONARY HYPERTENSION &amp; RENAL CELL CARCINOMA.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <IndependentConsultantInd>X</IndependentConsultantInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ALAN J BALCH</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>186611</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>125000</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>10800</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>1624</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>199035</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>125000</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>WILLIAM J NASON</PersonNm>
        <TitleTxt>CHIEF FINANCIAL OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>199571</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>6145</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>7983</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>17292</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>230991</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>FRANCES CASTELLOW</PersonNm>
        <TitleTxt>PRESIDENT OF OPERATIONS</TitleTxt>
        <BaseCompensationFilingOrgAmt>203175</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>6303</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>8127</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>1483</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>219088</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ANGELA M WALKER</PersonNm>
        <TitleTxt>CHIEF OF TALENT MANAGEMENT</TitleTxt>
        <BaseCompensationFilingOrgAmt>161401</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>4864</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>6378</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>1446</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>174089</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ERIN SINGLETON</PersonNm>
        <TitleTxt>CHIEF OF MISSION DELIVERY</TitleTxt>
        <BaseCompensationFilingOrgAmt>143041</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>4336</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>445</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>11737</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>159559</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ALAN RICHARDSON</PersonNm>
        <TitleTxt>EVP OF STRATEGIC PATIENT S</TitleTxt>
        <BaseCompensationFilingOrgAmt>141337</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>4330</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5653</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>16426</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>167746</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SAKHTI CHOKKALINGAM</PersonNm>
        <TitleTxt>SENIOR PEGA SYSTEMS ARCHIT</TitleTxt>
        <BaseCompensationFilingOrgAmt>155794</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>2360</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>6232</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>14970</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>179356</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SHONTA CHAMBERS</PersonNm>
        <TitleTxt>EVP OF HEALTH EQUITY INITIATIVES</TitleTxt>
        <BaseCompensationFilingOrgAmt>141661</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>4351</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5640</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>17672</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>169324</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>ALAN J BALCH</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>CHIEF EXECUTIVE OFFICER</RelationshipDescriptionTxt>
        <TransactionAmt>1199210</TransactionAmt>
        <TransactionDesc>PAF (PATIENT ADVOCATE FOUNDATION) AND NPAF (NATIONAL PATIENT ADVOCATE FOUNDATION) SHARE THE SAME CHIEF EXECUTIVE OFFICER. NPAF HAS A CONSULTING AGREEMENT IN WHICH PAF PAYS NPAF FEES TO REPRESENT THE POLICY INTERESTS OF PAF. THE CONSULTING FEES FOR FY 2017/2018 WERE $780,000. NPAF REIMBURSED PAF FOR SALARIES OF $232,972 FOR SHARED SERVICES, OF WHICH $125,000 WAS FOR ALAN BALCH'S SALARY. PAF ALSO REIMBURSED TO NPAF $129,228 IN SALARIES FOR SHARED SERVICES. NPAF ALSO REIMBURSED PAF FOR $6,448 OF OTHER EXPENSES, AND PAF REIMBURSED NPAF FOR $5,562 IN FY 2017/2018. PAF RECEIVED A GRANT FROM THE ROBERT WOOD JOHNSON FOUNDATION FOR DEVELOPING A WEBSITE, OF WHICH IT GRANTED $45,000 TO NPAF IN ORDER TO DEVELOP THE WEBSITE.</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>FRANCES CASTELLOW</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>PRESIDENT, OPERATIONS PAF</RelationshipDescriptionTxt>
        <TransactionAmt>222484</TransactionAmt>
        <TransactionDesc>RELATED PARTY IS THE DAUGHTER OF NANCY DAVENPORT-ENNIS, FOUNDER AND CHAIR EMERITA OF PAF.</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>BETH MOORE</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>EVP OF CORPORATE COMMUNICATIONS</RelationshipDescriptionTxt>
        <TransactionAmt>145112</TransactionAmt>
        <TransactionDesc>RELATED PARTY IS THE DAUGHTER OF NANCY DAVENPORT-ENNIS, FOUNDER AND CHAIR EMERITA OF PAF.</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>SHAWN NASON</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>SPECIAL EVENTS DIRECTOR</RelationshipDescriptionTxt>
        <TransactionAmt>77171</TransactionAmt>
        <TransactionDesc>RELATED PARTY IS THE WIFE OF WILLIAM NASON, CHIEF FINANCIAL OFFICER OF PAF.</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>AUCTION PRIZES</Desc>
        <ContributionCnt>204</ContributionCnt>
        <NoncashContributionsRptF990Amt>38374</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>COMPARABLE SALES</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>0</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4C</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUATION OF EXPLANATION OF PROGRAM SERVICES FROM PART III, LINE 4C WEST VIRGINIA HAS THE HIGHEST LUNG CANCER MORTALITY RATE IN THE COUNTRY, SURPASSING KENTUCKY TO TAKE THE NUMBER ONE SPOT IN 2017. ONE PRIMARY FACTOR CONTRIBUTING TO THIS HIGH MORTALITY RATE IS LATE STATE DIAGNOSIS. ROUTINELY, WEST VIRGINIAN'S DIAGNOSED WITH LUNG CANCER ARE DIAGNOSED AT STAGE THREE AND FOUR. TO ADDRESS THIS DISPARITY, PAF JOINED FORCES WITH LOCAL WEST VIRGINIA STAKEHOLDERS TO LAUNCH THE WEST VIRGINIA LUNG CANCER PROJECT. THE WEST VIRGINIA (WV) LUNG CANCER PROJECT IS DESIGNED TO LINK INDIVIDUALS AT RISK FOR OR DIAGNOSED WITH LUNG CANCER TO PAF'S CASE MANAGEMENT SUPPORT TO ASSIST THEM IN MITIGATING FINANCIAL AND LOGISTICAL BARRIERS TO CARE, INCLUDING ACCESS TO LUNG CANCER SCREENING, WITH SPECIFIC FOCUS ON MEDICAID BENEFICIARIES AND OTHER LOW-INCOME POPULATIONS ACROSS WEST VIRGINIA. THIS PROJECT IS CONDUCTED IN PARTNERSHIP WITH THE AMERICAN CANCER SOCIETY, WV UNIVERSITY CANCER INSTITUTE, WV MOUNTAINS OF HOPE CANCER COALITION, WV CANCER AND TOBACCO PROGRAMS, AETNA BETTER HEALTH (WV CMO) AND THE WV HOSPITAL ASSOCIATION. CRITICAL TO THIS PROJECT ARE THE MEDICAID AND MEDICAID MANAGED CARE ORGANIZATIONS (MMCO) AND THE PROVIDERS WITHIN THESE NETWORKS PROVIDING SERVICES ACROSS WEST VIRGINIA. PAF CONTINUES TO WORK WITH AETNA BETTER HEALTH OUR INITIAL MEDICAID MANAGED CARE PARTNER. AS A RESULT OF THIS PARTNERSHIP THE FOLLOWING HAS BEEN ACHIEVED DURING FY2017/2018: -1,333 AETNA MEMBERS WERE PROACTIVELY CONTACTED AND EDUCATED ABOUT SCREENING GUIDELINES -111 SCHEDULED AN APPOINTMENT TO TALK TO THEIR PROVIDER ABOUT LUNG CANCER SCREENING, -43 KEPT THEIR APPOINTMENT WITH THEIR PROVIDER, -14 COMPLETED A LDCT SCREENING, -9 WERE NEGATIVE FOR LUNG CANCER, -4 NEED ADDITIONAL TESTING, AND -1 WAS POSITIVE FOR CANCER AND HAS STARTED TREATMENT. COLLECTIVELY, THE FIVE MMCO OPERATING IN WEST VIRGINIA PROVIDE HEALTH CARE BENEFITS TO WEST VIRGINIA MEDICAID EXPANSION POPULATION, CREATING AN OPPORTUNITY TO LINK THOSE WHO MAY BE FINANCIAL VULNERABLE TO PAF AT A TIME WHEN THEY COULD BENEFIT FROM OUR SUPPORT THE MOST. IN ADDITION TO OUR MEDICAID MANAGED CARE PARTNER, ONE LOCAL HEALTH CARE SYSTEM LAUNCHED ITS LUNG CANCER SCREENING PROGRAM IN OCTOBER 2017 AND AS OF JANUARY 2018, HAD CONDUCTED 103 LDCT SCANS. IN FY2017/2018 PAF WAS THE RECIPIENT OF TWO GRANTS FROM THE ROBERT WOOD JOHNSON FOUNDATION (RWJF), INCLUDING "ROADMAP TO CONSUMER CLARITY DISSEMINATION PROJECT AND "RAISING AWARENESS OF THE IMPORTANCE OF AND FACILITATING COST-OF-CARE DISCUSSIONS IN HEALTH CARE". THESE ARE THE SECOND AND THIRD GRANTS PAF HAS BEEN AWARDED BY RWJF. THE "ROADMAP TO CONSUMER CLARITY DISSEMINATION PROJECT" IS A COMPLIMENT TO AND EXTENSION OF THE WORK THAT WAS DONE UNDER PAF'S FIRST RWJF GRANT IN 2016, "CREATING A ROADMAP TO CONSUMER CLARITY IN HEALTH CARE DECISION MAKING. THIS INITIAL GRANT DEVELOPED A COMPREHENSIVE MODEL FOR IMPLEMENTING PERSONALIZED CARE ACROSS A WIDE-RANGE OF CLINICAL SETTINGS. THE DISSEMINATION GRANT PROVIDED A MEANS TO TAKE A KEY COMPONENT OF THAT MODEL, SKILLED COMMUNICATIONS, AND APPLY IT TO COMMUNITY SETTINGS. PAF, IN COLLABORATION WITH NATIONAL PATIENT ADVOCATE FOUNDATION (NPAF), WORKED WITH THREE COMMUNITY PARTNERS TO ACHIEVE THE GRANT'S OBJECTIVES, THE MOUNTAIN AREA HEALTH EDUCATION CENTER (MAHEC) IN ASHEVILLE, NORTH CAROLINA, THE UNIVERSITY OF ILLINOIS CHICAGO (UIC) AND THE NATIONAL MEDICAL ASSOCIATION (NMA) IN PHILADELPHIA. THE PRIMARY COMMUNITY BEING ENGAGED FOR THE MAHEC WORKSHOP WAS THE APPALACHIAN POPULATION, FOR UIC IT WAS AFRICAN AMERICAN AND LATINO CANCER PATIENTS, AND FOR THE NMA, AFRICAN AMERICAN PHYSICIANS. EACH PROGRAM WAS DEVELOPED IN CLOSE COORDINATION WITH THE COMMUNITY PARTNER AND ADDRESSED THE SPECIFIC NEEDS OF THE REGION AND ITS POPULATION. THE PROGRAMS WERE DESIGNED TO BE HIGHLY INTERACTIVE, INCLUDE SIGNIFICANT PARTICIPATION FROM A WIDE RANGE OF STAKEHOLDERS, INCLUDING PATIENTS AND ADVOCATES, AND STRESS SKILLS THAT CAN BE USED IN ACTUAL HEALTH CARE DECISION MAKING AT KEY POINTS DURING THE ILLNESS EXPERIENCES. THE INTENTION IS TO USE THESE WORKSHOPS AS MODELS FOR CONTINUING TO DEVELOP COLLABORATIVE EFFORTS WITH OTHER COMMUNITY PARTNERS TO ADVANCE THE PERSONALIZED CARE FOR BOTH PATIENTS AND THEIR HEALTH CARE TEAMS. THE FINANCIAL BURDEN OF FACING A SERIOUS ILLNESS OR DISABILITY CAN HAVE A SIGNIFICANT, OFTEN DEVASTATING IMPACT ON PATIENTS AND CAREGIVERS. THIS IMPACT CAN BE MEASURED BOTH IN TERMS OF DIRECT COSTS FOR TREATMENT AND CARE AND DECISIONS THAT PEOPLE MAKE ABOUT THEIR LIVES WHEN THEY INCUR MEDICAL DEBT. IT IS INCREASINGLY IMPORTANT THAT PATIENTS DISCUSS THE COSTS OF THEIR CARE WITH THEIR HEALTH CARE PROVIDERS AND INCORPORATE CONSIDERATIONS OF FINANCIAL BURDEN IN THE DECISION-MAKING PROCESS. OPEN, HONEST CONVERSATIONS ARE MORE IMPORTANT AND RELEVANT TO ASSESSING TREATMENT OPTIONS AND HELPING PATIENTS CHOOSE AND REMAIN ON THEIR TREATMENT PLANS. IN 2017, THE ROBERT WOOD JOHNSON FOUNDATION FUNDED EIGHT DIVERSE INVESTIGATORS TO DO EXPLORATORY RESEARCH ON BARRIERS AND OPPORTUNITIES THAT EXIST FOR FACILITATING COST OF CARE DISCUSSIONS AND INTEGRATING THEM INTO THE CLINICAL WORK FLOW. THIS FUNDING SUPPORTED PAF'S PROJECT, "RAISING AWARENESS OF THE IMPORTANCE OF AND FACILITATING COST-OF-CARE DISCUSSIONS IN HEALTH CARE". THAT ACTIVITIES UNDER THIS GRANT HAVE BEEN COMPLETED AND RWJF HAS FUNDED SEVERAL ORGANIZATIONS, INCLUDING PAF TO DEVELOP INNOVATIVE MEANS OF DISSEMINATING THESE FINDINGS AND RAISING AWARENESS OF THE IMPORTANCE OF COST OF CARE DISCUSSIONS IN HEALTH CARE. PAF, IN COLLABORATION WITH NPAF, IS CURRENTLY DEVELOPING A WEBSITE FOR THIS PURPOSE, WILL SPONSOR A SERIES OF WEBINARS ON COST OF CARE RELATED TOPICS AND DEDICATE ITS POLICY CONSORTIUM TO COST OF CARE RELATED ISSUES. SCHOLARSHIP FOR SURVIVORS PROGRAM DURING PAF'S DAILY INTERACTIONS WITH PATIENTS, PAF STAFF OFTEN INTERFACE WITH PATIENTS WHO EITHER THEMSELVES OR A LOVED ONE HAS EXPERIENCED THE IMPACT OF A CHRONIC ILLNESS OR LIFE-THREATENING DISEASE ON ONE'S POST- SECONDARY EDUCATION. IN 2000, THE SCHOLARSHIP FOR SURVIVORS PROGRAM WAS ESTABLISHED TO HONOR THESE INDIVIDUALS BY OFFERING EDUCATIONAL SCHOLARSHIPS TO INDIVIDUALS WHO HAVE SUFFERED (OR ARE SUFFERING) A LIFE-THREATENING DISEASE OR CHRONIC CONDITION. THESE STUDENTS HAVE, DESPITE THEIR DISEASE/CONDITION, EXCELLED ACADEMICALLY, SERVED THE COMMUNITY, AND DESIRE TO PURSUE A SECONDARY EDUCATION. DONORS GIVING DURING SILENT AND LIVE AUCTIONS AT PATIENT ADVOCATE FOUNDATION'S 17TH ANNUAL A PROMISE OF HOPE AFFAIR, AS WELL AS A PAF STAFF GUIDED COMMUNITY FUNDRAISING INITIATIVE, HELPED MAKE IT POSSIBLE TO DRAMATICALLY EXPAND THE SCHOLARSHIP FOR SURVIVORS PROGRAM FROM TWELVE TO TWENTY STUDENTS FOR THE UPCOMING ACADEMIC YEAR. TO DATE, PAF HAS AWARDED 95 SCHOLARSHIPS TOTALING OVER $542,000.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>JOHN L. MURPHY, BOARD MEMBER AND FINANCE COMMITTEE CHAIR OF PATIENT ADVOCATE FOUNDATION, IS THE BROTHER-IN-LAW OF NANCY DAVENPORT-ENNIS, FOUNDER AND CHAIR EMERITA OF PATIENT ADVOCATE FOUNDATION. JOHN H. ENNIS, BOARD MEMBER AND CO-FOUNDER, IS THE HUSBAND OF NANCY DAVENPORT-ENNIS, FOUNDER AND CHAIR EMERITA OF PATIENT ADVOCATE FOUNDATION. FRANCES CASTELLOW, PRESIDENT, OPERATIONS OF PATIENT ADVOCATE FOUNDATION, IS THE DAUGHTER OF NANCY DAVENPORT-ENNIS, FOUNDER AND CHAIR EMERITA OF PATIENT ADVOCATE FOUNDATION. BETH MOORE, EVP OF CORPORATE COMMUNICATIONS OF PATIENT ADVOCATE FOUNDATION, IS THE DAUGHTER OF NANCY DAVENPORT-ENNIS, FOUNDER AND CHAIR EMERITA OF PATIENT ADVOCATE FOUNDATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS RECEIVES A DRAFT COPY OF THE FORM 990 THEN SUBSEQUENTLY REVIEWS IT FOR ACCURACY AND COMPLIANCE. ONCE IT IS APPROVED BY THE FINANCE COMMITTEE, ALL MEMBERS OF THE EXECUTIVE BOARD OF DIRECTORS RECEIVE THE FINAL COPY OF THE FORM 990 FOR REVIEW AND APPROVAL PRIOR TO FILING AND IS SO NOTED IN THE BOARD MEETING MINUTES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>MEMBERS OF THE PAF BOARD OF DIRECTORS ARE REQUIRED TO REVIEW AND SIGN THE CONFLICT OF INTEREST POLICY UPON ESTABLISHING MEMBERSHIP AND ANNUALLY COMPLETE AN UPDATED CONFLICT OF INTEREST DISCLOSURE QUESTIONNAIRE. EACH MEMBER MUST DISCLOSE ANY/ALL KNOWN CONFLICTS OF INTEREST AT THAT TIME. IF ANY CONFLICTS OF INTEREST ARE NOTED MORE INFORMATION WILL BE GATHERED BY THE GOVERNANCE &amp; COMPLIANCE COMMITTEE AND A DETERMINATION ON THE EXISTENCE OF A MATERIAL CONFLICT WILL BE ISSUED. THE GOVERNANCE &amp; COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS IS CHARGED WITH ENFORCEMENT OF THIS POLICY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>PATIENT ADVOCATE FOUNDATION COMPLETES COMPENSATION STUDIES THAT UTILIZE NATIONAL COMPARABILITY DATA OF ORGANIZATIONS SIMILAR IN MISSION, SIZE AND REVENUES. PAF HAS A COMPENSATION COMMITTEE WITHIN THE BOARD OF DIRECTORS THAT CONSISTS OF AT LEAST 4 INDEPENDENT EXECUTIVE BOARD MEMBERS AND IS CHAIRED BY THE BOARD PRESIDENT. THIS COMMITTEE IS PROVIDED WITH THE COMPENSATION REPORT AND UTILIZES IT TO ESTABLISH THE CEO'S ANNUAL COMPENSATION. THIS COMMITTEE ALSO REVIEWS THE COMPENSATION OF KEY EMPLOYEES UTILIZING THE COMPENSATION REPORT. THIS PROCESS IS DOCUMENTED THROUGH MINUTES OF THE COMPENSATION COMMITTEE MEETING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>PATIENT ADVOCATE FOUNDATION MAKES AVAILABLE THE LAST 10 YEARS OF FORM 990S, AUDITED FINANCIAL STATEMENTS, ANNUAL REPORTS AND CURRENT LIST OF BOARD MEMBERS ON THE ORGANIZATION'S WEBSITE, WWW.PATIENTADVOCATE.ORG UNDER THE "MEET PAF" SECTION. ADDITIONALLY, PAF MAKES AVAILABLE THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, ARCHIVED FORM 990S (OLDER THAN 10 YEARS) AND AUDITED FINANCIAL STATEMENTS (OLDER THAN 10 YEARS) UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9:</FormAndLineReferenceDesc>
        <ExplanationTxt>POSTRETIREMENT BENEFIT CHANGES OTHER THAN PERIODIC BENEFITS/COSTS -255,504.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C</FormAndLineReferenceDesc>
        <ExplanationTxt>NO CHANGES WERE MADE TO THE ORGANIZATION OVERSIGHT PROCESS OR SELECTION PROCESS DURING THE TAX YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCH A, PART II, SECTION C, LINE 17A, FACTS AND CIRCUMSTANCES TEST</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUED FROM SCHEDULE A (A). IN FY2017/2018, THE FOUNDATION ADMINISTERED CO-PAYMENT ASSISTANCE TO 89,963 QUALIFIED PATIENTS, A 20% INCREASE OVER FY2016/2017, THROUGH THE 25 ASSISTANCE FUNDS AVAILABLE THROUGH THE CO-PAY RELIEF PROGRAM. THE PROGRAM STAFF FIELDED 255,389 TELEPHONE CALLS AND PROCESSED CLAIMS, TOTALING $269,799,000, IN SUPPORT OF QUALIFIED PATIENTS' OUT OF POCKET EXPENSES FOR REQUIRED CO-PAYMENTS, CO-INSURANCE AND DEDUCTIBLES. SINCE ITS INCEPTION IN 2004, THE FOUNDATION HAS PROVIDED CO-PAYMENT ASSISTANCE TO OVER 325,000 INDIVIDUALS ALLOCATING MORE THAN $750 MILLION DOLLARS IN CO-PAYMENT AWARDS. HEALTH EQUITY INITIATIVE, COMMUNITY OUTREACH &amp; PATIENT ENGAGEMENT PATIENT ADVOCATE FOUNDATION CONTINUES TO EXPAND ITS REACH BEYOND DIRECT PATIENT SERVICES TO POPULATION HEALTH AS IT CONTINUES ITS' WORK UNDER A 5-YEAR COOPERATIVE AGREEMENT WITH THE CENTERS FOR DISEASE CONTROL AND PREVENTION, JOINTLY FUNDED THROUGH THE OFFICE OF SMOKING AND HEALTH AND DIVISION OF CANCER CONTROL. THROUGH THIS AWARD, PATIENT ADVOCATE FOUNDATION ADMINISTERS THE SELFMADE HEALTH NETWORK (SMHN), A MEMBER OF THE CDC'S CONSORTIUM OF NATIONAL NETWORKS TO IMPACT POPULATIONS EXPERIENCING TOBACCO-RELATED AND CANCER HEALTH DISPARITIES. THE SMHN FOCUSES ON IMPLEMENTING BEST AND PROMISING PRACTICES TO REDUCE TOBACCO AND CANCER RELATED DISPARITIES AMONG POPULATIONS WITH LOW SOCIOECONOMIC STATUS (SES) CHARACTERISTICS INCLUDING VULNERABLE, UNDERSERVED AND LOW-RESOURCED POPULATIONS, RESIDING IN RURAL, URBAN AND FRONTIER REGIONS. IN FY2017/2018, SMHN AND ITS PARTNER, UNIVERSITY OF KENTUCKY SCHOOL OF PUBLIC HEALTH, WERE SELECTED FOR ORAL PRESENTATION AT THE 2017 CDC NATIONAL CANCER CONFERENCE. THE PRESENTATION HIGHLIGHTED INITIAL FINDINGS FROM THE KENTUCKY TOBACCO CESSATION WORKSITE PILOT DESIGNED TO WORK WITH BLUE COLLAR WORKSITES TO BOTH PROMOTE AND ADOPT TOBACCO-FREE POLICIES AND PROVIDE LUNG CANCER EDUCATION AND CESSATION SUPPORT. THE PROJECT HAS ENGAGED WITH LOCAL WORKSITES ACROSS KENTUCKY BENEFITING OVER 1,000 BLUE COLLAR EMPLOYEES. IN ADDITION TO THE NOTED CDC CONFERENCE, SMHN HAD TWO POSTERS SELECTED FOR THE TENTH AACR CONFERENCE ON THE SCIENCE OF CANCER HEALTH DISPARITIES. ONE POSTER HIGHLIGHTED THE AFRICAN-AMERICAN BREAST CANCER WORK LED BY SMHN REGIONAL RESOURCE LEAD ORGANIZATION, MEHARRY MEDICAL COLLEGE AND THE OTHER FEATURED THE KENTUCKY TOBACCO CESSATION WORKSITE PROJECT, LED BY SMHN REGIONAL RESOURCE LEAD ORGANIZATION, UNIVERSITY OF KENTUCKY-SCHOOL OF PUBLIC HEALTH. THE AACR PRESENTATION AFFORDED SMHN THE OPPORTUNITY TO BE AT THE INTERFACE OF ACADEMIA, INDUSTRY, COMMUNITY AND RESEARCH TO MAXIMIZE OPPORTUNITIES TO SPECIFICALLY ADDRESS CANCER DISPARITIES AMONG LOW SES POPULATIONS. NOTABLE SMHN ACCOMPLISHMENTS IN FY2017/2018 INCLUDE: IN PARTNERSHIP WITH GEOGRAPHIC HEALTH EQUITY ALLIANCE, SMHN DEVELOPED ITS FIRST FACT SERIES FOR BLUE COLLAR WORKSITE ENTITLED "HEALTHIER NATION". THE SERIES WAS FEATURED IN THE TRUST FOR AMERICA'S HEALTH NEWSLETTER AND DISSEMINATED TO MORE THAN 9,000 SUBSCRIBERS. TWO KEY FUNCTIONS OF THE SMHN ARE THE PROVISION OF TECHNICAL ASSISTANCE (TA) TO STATE CANCER AND TOBACCO PREVENTION AND CONTROL PROGRAM, AND RECOMMENDATIONS TO CDC. OVER THE LAST YEAR, SMHN HAS PROVIDED TA TO STATE CANCER CONTROL PLANS FOR VA, WV AND TX, AND STATE TOBACCO CONTROL PLANS FOR NE, IL, AND MA. SPECIFICALLY, SMHN CO-DEVELOPED THE DISPARITIES SECTION OF THE VIRGINIA DEPARTMENT OF HEALTH'S 2018-2022 STATE CANCER PLAN. ADDITIONALLY, SMHN PROVIDED GUIDANCE TO THE CDC DIVISION OF CANCER PREVENTION AND CONTROL IN THE DEVELOPMENT OF WHAT WILL BE THE FIRST NATIONAL NETWORKS SNAPSHOT DOCUMENT. SMHN ALSO HELD AN "INSIDE KNOWLEDGE: GETS THE FACTS ABOUT GYNECOLOGICAL CANCER" EDUCATIONAL SESSION ON FRIDAY, JUNE 29, 2018 AT HOWARD UNIVERSITY, A HISTORICALLY BLACK UNIVERSITY IN WASHINGTON, D.C. SESSION ATTENDEES (42) INCLUDED RISING SOPHOMORE AND JUNIOR FEMALES PARTICIPATING IN THE SUMMER HEALTH PROFESSIONS EDUCATION PROGRAM (SHPEP) AT HOWARD UNIVERSITY. SMHN INITIATED TWO COMMUNITY LEVEL INITIATIVES DURING FY2017/2018 FOCUSED ON TOBACCO CESSATION WITH THE SOUTH CAROLINA TOBACCO FREE COLLABORATIVE (SCTFC) AND THE ALABAMA DEPARTMENT OF PUBLIC HEALTH (ADPH) TOBACCO CONTROL PROGRAM. THE SCTFC PROJECT IS A HEALTH SYSTEM INTERVENTION DESIGNED TO INCREASE CAPACITY OF LOCAL FEDERALLY QUALIFIED HEALTH SYSTEM TO ASSESS FOR AND REFER TOBACCO USERS TO TOBACCO CESSATION SUPPORT AS S PART OF THEIR STANDARD OPERATING PROCEDURES. A MEMORANDUM OF UNDERSTANDING HAS BEEN ESTABLISHED WITH THE SOUTH CAROLINA STATE OFFICE OF RURAL HEALTH SUPPORT RECRUITMENT OF RURAL HEALTH CLINICS TO PARTICIPATE IN PROJECT. A SERIES OF TRAINING, INCLUDING CERTIFIED TOBACCO CESSATION SPECIALIST ARE SLATED TO BEGIN IN JULY 2018. SELFMADE HEALTH NETWORK CONTINUED TO EXPAND THE REACH OF THE NETWORK IN FY2017/2018 BY SEEKING AND ENGAGING WITH ORGANIZATIONS ACROSS THE PUBLIC HEALTH SPECTRUM WITH BROAD REACH. AS A RESULT OF THIS EFFORT, SMHN HAS EXPANDED ITS REACH BY 143,816 AND RECORDED MORE THAN 243,400 IMPRESSIONS ON TWITTER. PAF SUBMITTED A GRANT APPLICATION FOR CONSIDERATION UNDER THE NETWORKING2SAVE CDC'S NATIONAL NETWORK APPROACH TO PREVENTING AND CONTROLLING TOBACCO-RELATED CANCERS IN SPECIAL POPULATIONS (DP 18-1808) FUNDING OPPORTUNITY. THIS NOFO WAS DESIGNED TO FUND A CONSORTIUM OF NATIONAL NETWORKS TO IMPLEMENT POPULATION-SPECIFIC, PUBLIC HEALTH-ORIENTED STRATEGIES THAT IMPACT THE PREVALENCE OF COMMERCIAL TOBACCO USE AND TOBACCO RELATED CANCERS. STRATEGIES AND ACTIVITIES WILL FOCUS ON NETWORK ADMINISTRATION AND MANAGEMENT; TRAINING AND TECHNICAL ASSISTANCE; ENGAGEMENT OF THE TARGET POPULATIONS IN NATIONAL, STATE, TRIBAL, TERRITORIAL INTERVENTIONS; AND MASS REACH HEALTH COMMUNICATIONS. PAF WAS SELECTED AS A GRANTEE UNDER THIS FUNDING OPPORTUNITY AND WAS AWARDED A 5-YEAR GRANT FOR THE PERIOD OF 2018-2023. THE TARGET POPULATION THAT PAF WAS FUNDED TO ADDRESS ARE PERSONS WITH LOW SOCIOECONOMIC STATUS. WE WILL ACCOMPLISH THIS WORK THROUGH THE CONTINUED ADMINISTRATION OF THE SELFMADE HEALTH NETWORK WHICH WE ESTABLISHED UNDER THE PREVIOUS AWARD (DP 13-1314). AS EVIDENCE OF PAF'S COMMITMENT TO CONTINUALLY BROADENING THE WAY PAF SUPPORTS PATIENTS LIVING WITH CHRONIC AND CRITICAL DISEASE, THE WEST VIRGINIA (WV) LUNG CANCER PROJECT WAS LAUNCHED BY PAF IN FY2016/2017 AS A MULTI-YEAR PROJECT. THE WEST VIRGINIA (WV) LUNG CANCER PROJECT IS DESIGNED TO LINK INDIVIDUALS AT RISK FOR OR DIAGNOSED WITH LUNG CANCER TO PAF'S CASE MANAGEMENT SUPPORT TO ASSIST THEM IN MITIGATING FINANCIAL AND LOGISTICAL BARRIERS TO CARE, INCLUDING ACCESS TO LUNG CANCER SCREENING, WITH SPECIFIC FOCUS ON MEDICAID BENEFICIARIES AND OTHER LOW-INCOME POPULATIONS ACROSS WEST VIRGINIA. THIS PROJECT IS CONDUCTED IN PARTNERSHIP WITH THE AMERICAN CANCER SOCIETY, WV UNIVERSITY CANCER INSTITUTE, WV MOUNTAINS OF HOPE CANCER COALITION, WV CANCER AND TOBACCO PROGRAMS, AETNA BETTER HEALTH (WV CMO) AND THE WV HOSPITAL ASSOCIATION. CRITICAL TO THIS PROJECT ARE THE MEDICAID AND MEDICAID MANAGED CARE ORGANIZATIONS (MMCO) AND THE PROVIDERS WITHIN THESE NETWORKS PROVIDING SERVICES ACROSS WEST VIRGINIA. PAF CONTINUED TO WORK WITH AETNA BETTER HEALTH OUR INITIAL MEDICAID MANAGED CARE PARTNER THIS YEAR. AS A RESULT OF THIS PARTNERSHIP THE FOLLOWING HAS BEEN ACHIEVED DURING FY2017/2018: 1,333 AETNA MEMBERS WERE PROACTIVELY CONTACTED AND EDUCATED ABOUT SCREENING GUIDELINES 111 SCHEDULED AN APPOINTMENT TO TALK TO THEIR PROVIDER ABOUT LUNG CANCER SCREENING, 43 KEPT THEIR APPOINTMENT WITH THEIR PROVIDER, 14 COMPLETED A LDCT SCREENING, 9 WERE NEGATIVE FOR LUNG CANCER, 4 NEED ADDITIONAL TESTING, AND 1 WAS POSITIVE FOR CANCER AND HAS STARTED TREATMENT. ONE LOCAL HEALTH CARE SYSTEM LAUNCHED ITS LUNG CANCER SCREENING PROGRAM IN OCTOBER 2017 AND AS OF JANUARY 2018, HAD CONDUCTED 103 LDCT SCANS. COLLECTIVELY, THE FIVE MMCO OPERATING IN WEST VIRGINIA PROVIDE HEALTH CARE BENEFITS TO WEST VIRGINIA MEDICAID EXPANSION POPULATION, CREATING AN OPPORTUNITY TO LINK THOSE WHO MAY BE FINANCIAL VULNERABLE TO PAF AT A TIME WHEN THEY COULD BENEFIT FROM PAF'S SUPPORT THE MOST. IN FY2017/2018 PAF WAS THE RECIPIENT OF TWO GRANTS FROM THE ROBERT WOOD JOHNSON FOUNDATION (RWJF), INCLUDING "ROADMAP TO CONSUMER CLARITY DISSEMINATION PROJECT AND "RAISING AWARENESS OF THE IMPORTANCE OF AND FACILITATING COST-OF-CARE DISCUSSIONS IN HEALTH CARE". THESE ARE THE SECOND AND THIRD GRANTS PAF HAS BEEN AWARDED BY RWJF. CONTINUED LATER IN SCHEDULE O (B).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCH A, PART II, SECTION C, LINE 17A, FACTS AND CIRCUMSTANCES TEST</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUATION FROM SCHEDULE O (B). THE "ROADMAP TO CONSUMER CLARITY DISSEMINATION PROJECT" IS A COMPLIMENT TO AND EXTENSION OF THE WORK THAT WAS DONE UNDER PAF'S FIRST RWJF GRANT IN 2016, "CREATING A ROADMAP TO CONSUMER CLARITY IN HEALTH CARE DECISION MAKING. THIS INITIAL GRANT DEVELOPED A COMPREHENSIVE MODEL FOR IMPLEMENTING PERSONALIZED CARE ACROSS A WIDE-RANGE OF CLINICAL SETTINGS. THE DISSEMINATION GRANT PROVIDED A MEANS TO TAKE A KEY COMPONENT OF THAT MODEL, SKILLED COMMUNICATIONS, AND APPLY IT TO COMMUNITY SETTINGS. PAF, IN COLLABORATION WITH NATIONAL PATIENT ADVOCATE FOUNDATION (NPAF), WORKED WITH THREE COMMUNITY PARTNERS TO ACHIEVE THE GRANT'S OBJECTIVES, THE MOUNTAIN AREA HEALTH EDUCATION CENTER (MAHEC) IN ASHEVILLE, NORTH CAROLINA, THE UNIVERSITY OF ILLINOIS CHICAGO (UIC) AND THE NATIONAL MEDICAL ASSOCIATION (NMA) IN PHILADELPHIA. THE PRIMARY COMMUNITY BEING ENGAGED FOR THE MAHEC WORKSHOP WAS THE APPALACHIAN POPULATION, FOR UIC IT WAS AFRICAN AMERICAN AND LATINO CANCER PATIENTS, AND FOR THE NMA, AFRICAN AMERICAN PHYSICIANS. EACH PROGRAM WAS DEVELOPED IN CLOSE COORDINATION WITH THE COMMUNITY PARTNER AND ADDRESSED THE SPECIFIC NEEDS OF THE REGION AND ITS POPULATION. THE PROGRAMS WERE DESIGNED TO BE HIGHLY INTERACTIVE, INCLUDE SIGNIFICANT PARTICIPATION FROM A WIDE RANGE OF STAKEHOLDERS, INCLUDING PATIENTS AND ADVOCATES, AND STRESS SKILLS THAT CAN BE USED IN ACTUAL HEALTH CARE DECISION MAKING AT KEY POINTS DURING THE ILLNESS EXPERIENCES. THE INTENTION IS TO USE THESE WORKSHOPS AS MODELS FOR CONTINUING TO DEVELOP COLLABORATIVE EFFORTS WITH OTHER COMMUNITY PARTNERS TO ADVANCE THE PERSONALIZED CARE FOR BOTH PATIENTS AND THEIR HEALTH CARE TEAMS. THE FINANCIAL BURDEN OF FACING A SERIOUS ILLNESS OR DISABILITY CAN HAVE A SIGNIFICANT, OFTEN DEVASTATING IMPACT ON PATIENTS AND CAREGIVERS. THIS IMPACT CAN BE MEASURED BOTH IN TERMS OF DIRECT COSTS FOR TREATMENT AND CARE AND DECISIONS THAT PEOPLE MAKE ABOUT THEIR LIVES WHEN THEY INCUR MEDICAL DEBT. IT IS INCREASINGLY IMPORTANT THAT PATIENTS DISCUSS THE COSTS OF THEIR CARE WITH THEIR HEALTH CARE PROVIDERS AND INCORPORATE CONSIDERATIONS OF FINANCIAL BURDEN IN THE DECISION-MAKING PROCESS. OPEN, HONEST CONVERSATIONS ARE MORE IMPORTANT AND RELEVANT TO ASSESSING TREATMENT OPTIONS AND HELPING PATIENTS CHOOSE AND REMAIN ON THEIR TREATMENT PLANS. IN 2017, THE ROBERT WOOD JOHNSON FOUNDATION FUNDED EIGHT DIVERSE INVESTIGATORS TO DO EXPLORATORY RESEARCH ON BARRIERS AND OPPORTUNITIES THAT EXIST FOR FACILITATING COST OF CARE DISCUSSIONS AND INTEGRATING THEM INTO THE CLINICAL WORK FLOW. THIS FUNDING SUPPORTED PAF'S PROJECT, "RAISING AWARENESS OF THE IMPORTANCE OF AND FACILITATING COST-OF-CARE DISCUSSIONS IN HEALTH CARE". THAT ACTIVITIES UNDER THIS GRANT HAVE BEEN COMPLETED AND RWJF HAS FUNDED SEVERAL ORGANIZATIONS, INCLUDING PAF TO DEVELOP INNOVATIVE MEANS OF DISSEMINATING THESE FINDINGS AND RAISING AWARENESS OF THE IMPORTANCE OF COST OF CARE DISCUSSIONS IN HEALTH CARE. PAF, IN COLLABORATION WITH NPAF, IS CURRENTLY DEVELOPING A WEBSITE FOR THIS PURPOSE, WILL SPONSOR A SERIES OF WEBINARS ON COST OF CARE RELATED TOPICS AND DEDICATE ITS POLICY CONSORTIUM TO COST OF CARE RELATED ISSUES. PATIENT EDUCATION &amp; EMPOWERMENT LASTLY, PAF EXTENDS THE IMPACT OF ITS ONE-TO-ONE CASE MANAGEMENT SERVICES THROUGH THE DEVELOPMENT AND DELIVERY OF PATIENT EDUCATION AND EMPOWERMENT TOOLS FOCUSED ON PROVIDING ACTIONABLE ADVICE AND GUIDANCE TO HEALTHCARE CONSUMERS TO IMPROVE THEIR EVERYDAY EXPERIENCE WITH INSURANCE AND TO ENCOURAGE PATIENT'S ENGAGEMENT IN THE HEALTHCARE SYSTEM. EACH YEAR, PAF CREATES, MAINTAINS AND DISTRIBUTES A WIDE ARRAY OF PATIENT EDUCATION MATERIALS AND ONLINE TOOLS, IN PRINTED AND ELECTRONIC FORM. PAF'S EDUCATIONAL PORTFOLIO COVERS A BROAD RANGE OF TOPICS, AVAILABLE IN A VARIETY OF FORMATS, TO MEET THE NEEDS AND PREFERENCES OF MULTIPLE AUDIENCES, INCLUDING PATIENTS, CAREGIVERS AND PROFESSIONALS INCLUDING THOSE WHO INTERACT DIRECTLY WITH THE FOUNDATION REQUESTING ASSISTANCE AS WELL AS THE GENERAL PUBLIC VISITING OUR WEBSITE AND CONNECTING WITH PAF. PAF'S PATIENT EDUCATION MATERIALS ARE ROUTINELY UTILIZED BY OTHER ORGANIZATIONS AND FACILITIES WHO SHARE THEM WITH THEIR PATIENTS. THE FOUNDATION MAINTAINS AN EXTENSIVE LIBRARY OF PAF AUTHORED PATIENT EDUCATIONAL PUBLICATIONS, AS WELL AS A CULTIVATED GROUP OF MATERIALS FROM OTHER INDUSTRY EXPERTS, ALL OF WHICH ARE AVAILABLE FREE OF CHARGE TO PATIENT. DURING FY2017/2018, THE FOUNDATION'S PATIENT EDUCATION AND EMPOWERMENT TEAM LAUNCHED A PATIENT INSIGHT AND REVIEWER PANEL CREATING A MECHANISM THROUGH WHICH FEEDBACK AND SUPPORT ON EDUCATIONAL PROJECTS OF ALL KINDS CAN BE OBTAINED IN A SYSTEMATIC AND RELIABLE MANNER, DEVELOPED 15 NEW AND REVISED EDUCATIONAL PUBLICATIONS, LAUNCHED 3 ONLINE EDUCATIONAL TOOLS AND CREATED 10 PATIENT EMPOWERMENT SERIES WEBINARS. THE INFRASTRUCTURE AND CONTENT OF THE NATIONAL FINANCIAL RESOURCE DIRECTORIES, THE MY RESOURCE SEARCH APP, WORDS THAT MATTER VOCABULARY AND GLOSSARY MATERIALS AND CHATTER THAT MATTERS VIDEOS WERE ALSO ENHANCED AND THE CONTENT EXPANDED. PATIENT EMPOWERMENT SERIES WEBCASTS PATIENT EMPOWERMENT SERIES WEBCASTS 15 ON-DEMAND SESSIONS AVAILABLE IN LIBRARY, 3 WERE PRESENTED LIVE DURING REPORTING PERIOD ATTENDEES UNIVERSALLY REPORT THAT WEBINARS ARE INFORMATIVE, VALUABLE AND PRESENTER IS KNOWLEDGEABLE ABOUT TOPIC. PAF'S PUBLICATION LIBRARY &amp; EXPERT PARTNER RESOURCES INCREASED USE OF ELECTRONIC DISTRIBUTION OF PUBLICATIONS, AND ONLINE CONTENT THROUGH EDUCATIONAL TEXT ARTICLES AND UPDATED PUBLICATION IMPROVED WEB DOWNLOAD EXPERIENCE FOR ELECTRONIC DISTRIBUTION OF PAF PUBLICATIONS WITH UPDATED PAF WEBSITE UPDATED ONLINE LAYOUT AND ORGANIZED EDUCATIONAL MATERIAL INTO 12 EASY TO UNDERSTAND TOPIC AREAS FOR QUICKER PATIENT ACCESS ADDITION OF SPANISH VERSIONS OF PUBLICATIONS FOR ELECTRONIC DOWNLOAD INTRODUCED NEW PUBLICATIONS "CLINICAL TRIALS ARE DEFINITELY WORTH A SECOND LOOK FOR ANY PATIENT", AND "UNDERSTANDING HOW SSI AND SSDI CAN HELP PATIENTS" NEARLY 30,000 MAILED PIECES OF PATIENT EDUCATIONAL MATERIALS DISTRIBUTED, PLUS OVER 17.000 ELECTRONICALLY SENT PAF NATIONAL RESOURCE DIRECTORIES &amp; MOBILE APP USERS COMPLETED 32,592 ELECTRONIC SEARCHES FOR RESOURCES 1,048,422 MATCHING RESOURCES WERE PROVIDED TO USERS 148 RESOURCES ADDED, 229 RESOURCES UPDATED, 50 RESOURCES CLOSED BY PAF STAFF FINANCIAL ASSISTANCE TYPES REPRESENT MOST COMMONLY SEARCHED CHARACTERISTIC PUBLISHED UPDATED VERSION IN APP STORES TO ACCOMMODATE CHANGES IN PHONE OPERATING SYSTEMS CUSTOMIZED MATERIAL FOR SPECIFIC PATIENT POPULATIONS DEVELOPMENT OF "MATTERS OF THE HEART" EDUCATIONAL SYNDICATION TOOL FOR PAF AND CARDIOVASCULAR NONPROFIT PARTNER USE CREATION OF 19 EDUCATIONAL TIP SHEETS TO ACCOMPANY THE "MATTERS OF THE HEART" MATERIAL FOR CARDIOVASCULAR PATIENTS PUBLISHED "CLINICAL TRIALS: WHAT PATIENT ADVOCATES WANT YOU TO KNOW" FOR METASTATIC BREAST CANCER PATIENTS DURING FY2017/2018, MEMBERS OF THE FOUNDATION'S STAFF CONDUCTED, PARTICIPATED IN AND HOSTED EDUCATIONAL OUTREACH AT THE LOCAL, REGIONAL AND NATIONAL LEVELS WITH THE GOAL OF EDUCATING THE GENERAL PUBLIC, NONPROFIT ORGANIZATIONS AND MEMBERS OF THE HEALTHCARE COMMUNITY WHO SUPPORT PATIENTS ABOUT THE SERVICES AND EDUCATIONAL MATERIALS OFFERED BY THE FOUNDATION AND THE CHALLENGES FACING PATIENTS AS THEY NAVIGATE THEIR TREATMENT JOURNEY. THIS OUTREACH WAS, IN SOME CASES, TARGETED TO A SPECIFIC POPULATION THAT IS KNOWN TO BE CONSIDERED DISPARATE IN HEALTHCARE ACCESS AND DISEASE OUTCOMES DATA. IN FY2017/2018, THE FOUNDATION ATTENDED 81OUTREACH EVENTS AND DISTRIBUTED OVER 5000 EDUCATIONAL PUBLICATIONS THROUGH THESE EVENTS. CONTINUED LATER IN SCHEDULE O (C).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCH A, PART II, SECTION C, LINE 17A, FACTS AND CIRCUMSTANCES TEST</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUATION FROM SCHEDULE O (C). PUBLIC SUPPORT PERCENTAGE THE FOUNDATION'S CUMULATIVE PUBLIC SUPPORT PERCENTAGE THROUGH JUNE 30, 2018 IS 23.83%, WHICH IS ABOVE THE MINIMUM AMOUNT OF 10% AT WHICH FACTS AND CIRCUMSTANCES WILL BE CONSIDERED BY THE IRS IN DETERMINING THE FOUNDATION'S ONGOING STATUS AS A PUBLIC CHARITY. PAF'S ONGOING OPERATIONS, GOVERNING STRUCTURE AND BROAD FUNDRAISING ACTIVITIES PRESENT A VERY STRONG CASE IN SUPPORT OF ITS ONGOING CLASSIFICATION AS A PUBLIC CHARITY. THESE FACTS AND CIRCUMSTANCES INCLUDE THE FOLLOWING: 1. THE FOUNDATION MAINTAINS ITS INDEPENDENCE FROM ITS DONORS BOTH OPERATIONALLY AND FROM A GOVERNANCE PERSPECTIVE. DONORS TO PAF DO NOT HAVE INFLUENCE OR CONTROL OVER THE FOUNDATION, ITS OPERATIONS OR ITS PROGRAMMING. IT IS IMPORTANT TO NOTE THAT, BY ITS' VERY NATURE, THE CO-PAY RELIEF PROGRAM, TO WHICH CHARITABLE DONATIONS ARE MADE THAT EFFECT PAF'S PUBLIC SUPPORT PERCENTAGE THE GREATEST, IS REQUIRED TO BE INDEPENDENTLY OPERATED, WITHOUT THE INFLUENCE OR CONTROL OF ITS DONORS PER GUIDANCE PROVIDED BY THE OFFICE OF INSPECTOR GENERAL (OIG) IN ITS OPINION 04-15. PAF HAS A DEEP COMMITMENT TO COMPLIANCE WITH ITS OIG OPINION, AS IS EVIDENCED BY ITS ORGANIZATIONAL COMPLIANCE PROGRAM AND ONGOING OUTCOMES INTERNAL AND EXTERNAL REVIEWS AND AUDITS. 2. PAF SEEKS, AND SUCCESSFULLY SECURES, FUNDING FOR ALL ITS PROGRAMS FROM A MULTITUDE OF SOURCES INCLUDING GOVERNMENTAL AGENCIES, OTHER PUBLIC CHARITIES, CORPORATIONS AND FROM THE GENERAL PUBLIC. 3. PAF'S EXECUTIVE BOARD OF DIRECTORS IS COMPRISED OF MEMBERS WITH DIVERSE PROFESSIONAL BACKGROUNDS, REPRESENTING THE INTERESTS OF THE CHRONICALLY AND CRITICALLY ILL SEGMENT OF THE GENERAL PUBLIC SERVED BY PAF. THE MEMBERS OF THE PAF BOARD OF DIRECTORS HAVE EXPERTISE IN THE FIELDS OF HEALTHCARE ADMINISTRATION, CLINICAL PRACTICE AND RESEARCH, DIRECT PATIENT CARE, NON-PROFIT MANAGEMENT, GOVERNMENT, PATIENT ADVOCACY, HEALTH INSURANCE, TECHNOLOGY AND LAW; WHEN COMBINED, THE MEMBERS CLEARLY REPRESENT A BROAD CROSS SECTION OF THE VIEWS AND INTERESTS OF THE COMMUNITY/PUBLIC. 4. THE FOUNDATION'S SUPPORT AND SERVICES BROADLY BENEFIT THE GENERAL PUBLIC, SPECIFICALLY THOSE DIAGNOSED AND LIVING WITH CHRONIC AND CRITICAL DISEASES, THEIR FAMILIES AND CARE TEAMS. PAF HAS A LONGSTANDING, DEMONSTRATED HISTORY OF PROVIDING ROBUST CASE MANAGEMENT SERVICES, PATIENT/PUBLIC EDUCATION AND THE PROVISION OF FINANCIAL SUPPORT FOR PHARMACEUTICAL CO-PAYMENTS THROUGH ITS CPR PROGRAM; CONTINUOUSLY FUNDRAISING TO AN EVER EXPANDING AND CHANGING DONOR BASE TO FUND THE PATIENT PROGRAMMING EACH YEAR. FACTS AND CIRCUMSTANCES SUPPORTING QUALIFICATION AS A PUBLICLY SUPPORTED ORGANIZATION 1. ATTRACTION OF PUBLIC SUPPORT &amp; INDEPENDENCE PAF IS ORGANIZED AND OPERATED IN A MANNER THAT FACILITATES AND ATTRACTS NEW AND ADDITIONAL PUBLIC AND GOVERNMENTAL SUPPORT, AS WELL AS SUPPORT FROM OTHER PUBLIC CHARITIES AND CORPORATIONS ON A CONTINUOUS BASIS. THIS IS EVIDENCED BY THE PUBLIC SUPPORT PERCENTAGE THAT PAF HAS MAINTAINED OVER THE COURSE OF ITS 22-YEAR HISTORY AND THE NUMBER AND DIVERSITY OF DONORS TO THE FOUNDATION. PAF HAS A POLICY OF SEEKING AND SECURING CHARITABLE DONATIONS FROM A MULTITUDE OF SOURCES FOR ALL ITS PROGRAMS, INCLUDING CASE MANAGEMENT, PATIENT EDUCATION AND EMPOWERMENT PROGRAMS, HEALTH EQUITY INITIATIVES, AND FINANCIAL ASSISTANCE PROGRAMS INCLUDING ITS FINANCIAL AID FUNDS (FAF) AND ITS CO-PAY RELIEF (CPR) PROGRAM AS OUTLINED IN OIG ADVISORY OPINION 04-15. PAF HAS BEEN SUCCESSFUL IN SECURING BROAD SUPPORT FROM A MYRIAD OF SOURCES, EXPANDING ITS BASE OF SUPPORT EACH YEAR. PAF DOES NOT HAVE A PERPETUAL SOURCE OF REVENUE (I.E. LARGE ENDOWMENT FROM WHICH INVESTMENT INCOME MIGHT SUPPORT THE ORGANIZATION, AS IS THE CASE WITH MOST PRIVATE FOUNDATIONS), RATHER, THE FOUNDATION'S LEADERSHIP, AND THOSE STAFF CHARGED WITH FUNDRAISING ACTIVITIES, ARE RESPONSIBLE FOR SECURING SUPPORT SUFFICIENT ENOUGH TO SUPPORT THE FOUNDATION'S PROGRAM SERVICES FOR THE GENERAL PUBLIC EACH YEAR. THE FOUNDATION EMPLOYS A PROGRAM DEVELOPMENT STAFF OF FIVE (5) WHOM, IN PARTNERSHIP WITH THE CEO AND BOARD OF DIRECTORS, IS RESPONSIBLE FOR DEVELOPING AND EXECUTING MULTIFACETED FUNDRAISING PLANS ALIGNED WITH THE MISSION OF THE FOUNDATION OF PROVIDING SUSTAINED CASE MANAGEMENT, FINANCIAL SUPPORT AND EDUCATION TO THE UN- AND UNDER- INSURED, FINANCIALLY DISADVANTAGED POPULATION IN OUR NATION. THE PROGRAM DEVELOPMENT TEAM WORKS TO IDENTIFY AND RESPOND TO FUNDING OPPORTUNITIES FOR THE FOUNDATION FROM ALL GOVERNMENT, BUSINESS AND NON-PROFIT SECTORS. IN FY2017/2018, THE PROGRAM DEVELOPMENT STAFF SUBMITTED 235 GRANTS AND FACILITATED FUNDRAISING CAMPAIGNS TO THE GENERAL PUBLIC. THIS REPRESENTS A 7% INCREASE IN GRANT SUBMISSIONS AS COMPARED TO FY2016/2017. FURTHER IN 2017/2018, PAF RECEIVED DONATIONS OF SUPPORT FROM THIRTY-THREE (33) NON-PROFIT ORGANIZATIONS, ALL 501C3 PUBLIC CHARITIES AND PRIVATE FOUNDATIONS, OF WHICH 13 WERE NEW DONORS. THESE ORGANIZATIONS FUNDED GRANTS TO PAF IN SUPPORT OF ITS CASE MANAGEMENT, PATIENT EDUCATION, FINANCIAL AID FUNDS AND CO-PAY RELIEF PROGRAM. GRANT SUPPORT FROM NON-PROFIT ORGANIZATIONS REPRESENTED THE MAJORITY OF FUNDING FOR THE PAF CASE MANAGEMENT PROGRAMS. IN FY2017/2018, PAF ALSO EXPANDED ITS RELATIONSHIP WITH THE BEGIN AGAIN FOUNDATION, WHO IN ADDITION TO PROVIDING CONTINUED SUPPORT FOR THE LEISHLINE FAF EXPANDED TO SUPPORT CASE MANAGEMENT SERVICES. THE ROBERT WOOD JOHNSON FOUNDATION EXPANDED THEIR SUPPORT TO INCLUDE A SECOND YEAR OF FUNDING FOR DISSEMINATION OF THE PREVIOUS YEAR'S RESEARCH PROJECT. PAF SECURED SPONSORSHIPS AND SOLD TICKETS FOR ITS BLACK-TIE FUNDRAISER, PROMISE OF HOPE AFFAIR, IN FEBRUARY 2018, ATTENDED BY MORE THAN 300 ATTENDEES WHO SUPPORTED PAF AT THE EVENT AS WELL THROUGH LIVE AND SILENT AUCTIONS. PAF MAINTAINS, ON ITS PUBLIC WEBSITES, (WWW.PATIENTADVOCATE.ORG AND WWW.COPAYS.ORG ), DONATION PAGES THAT THE GENERAL PUBLIC USES TO MAKE DONATIONS TO THE FOUNDATION. PAF DEVELOPMENT TEAM DESIGNS AND LAUNCHES SEVERAL INDIVIDUAL APPEAL CAMPAIGNS ANNUALLY. FURTHER, PAF MAINTAINS CLEAR INDEPENDENCE OF OPERATIONS OF ITS PROGRAMS SO TO ENSURE THEY ARE DESIGNED AND OPERATED IN A MANNER THAT ADDRESSES THE NEEDS OF CHRONICALLY AND CRITICALLY ILL PATIENTS IN THE GENERAL POPULATION AS SUPPORTED BY PAF PATIENT NEEDS DATA. PAF INDEPENDENTLY, AND WITHOUT DONOR INFLUENCE OR CONTROL, IDENTIFIES THE NEED FOR, AND DEFINES AND ESTABLISHES THE OPERATIONAL PARAMETERS FOR, EACH OF ITS DISEASE SPECIFIC FUNDS IN THE CPR PROGRAM CONSISTENT WITH ITS OIG ADVISORY OPINION, 04-15, AS MODIFIED AND ALL PUBLISHED OIG GUIDANCE THAT IS APPLICABLE TO CHARITABLE PATIENT ASSISTANCE PROGRAMS. PAF ALSO IDENTIFIES THE NEED FOR, DEFINES AND ESTABLISHES THE OPERATIONAL PARAMETERS FOR ITS CASE MANAGEMENT PROGRAMMING, SMALL GRANT PROGRAMS AND PUBLIC/PATIENT EDUCATION PROGRAMS, FREE FROM DONOR INFLUENCE OR CONTROL. THE PAF BOARD OF DIRECTORS ADOPTED THE CHARITABLE PATIENT ASSISTANCE PROGRAM (CPAP) CODE OF ETHICS THAT WAS DRAFTED IN 2014-2015 BY A COLLECTION OF ORGANIZATIONS WHO ALL PROVIDE CHARITABLE PATIENT ASSISTANCE SIMILAR TO THAT PROVIDED BY PAF THROUGH ITS CO-PAY RELIEF PROGRAM. THIS INITIATIVE WAS LED BY PAF AND MANAGED BY REGULATORY COUNSEL FROM WASHINGTON, DC. PAF HAS A GOVERNANCE COMMITTEE OF THE BOARD OF DIRECTORS. MEMBERSHIP ON THIS COMMITTEE IS LIMITED TO INDEPENDENT BOD MEMBERS AND NO MEMBER CAN HAVE ANY RELATIONSHIP TO A DONOR ORGANIZATION. ADOPTION OF THIS VOLUNTARY CODE FURTHER DEMONSTRATES PAF'S COMMITMENT TO COMPLIANCE AND INDEPENDENCE FROM DONOR INFLUENCE. ARENT FOX, LLP, WHO ARE EXPERTS IN REGULATORY COMPLIANCE, SPECIALIZING IN COMPLIANCE PROGRAMS RELATIVE TO PATIENT ASSISTANCE PROGRAMS, PROVIDE MANAGEMENT OF PAF'S ORGANIZATIONAL COMPLIANCE PROGRAM, AS WELL AS SERVE AS COMPLIANCE COUNSEL. ALL PROGRAMS OPERATED BY PAF, INCLUDING CPR, ARE MONITORED AND EVALUATED AS PART OF THE COMPLIANCE PROGRAM, AS DEFINED IN THE COMPLIANCE CHARTER. THE PROGRAM IS DESIGNED TO ASSIST THE FOUNDATION IN PREVENTING, DETECTING, AND RESPONDING TO ILLEGAL, IMPROPER, AND UNETHICAL CONDUCT, SERVING AS A PROCEDURAL FRAMEWORK FOR ENHANCING AND MONITORING COMPLIANCE WITH APPLICABLE LAW, REGULATION, THE PAF CODE OF CONDUCT, THE CHARITABLE PATIENT ASSISTANCE PROGRAM CODE OF ETHICS AND THE FOUNDATION'S POLICIES AND PROCEDURES. CONTINUED LATER IN SCHEDULE O (D).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCH A, PART II, SECTION C, LINE 17A, FACTS AND CIRCUMSTANCES TEST</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUATION FROM SCHEDULE O (D). THE COMPLIANCE PROGRAM IS BASED ON THE ELEMENTS OF AN EFFECTIVE COMPLIANCE PROGRAM SET FORTH IN THE FEDERAL SENTENCING GUIDELINES MANUAL AND APPLICABLE DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF INSPECTOR GENERAL GUIDANCE. KEY PROGRAM GOVERNANCE POLICIES AND PROCEDURES INCLUDE: 1. COMPLIANCE PROGRAM OVERVIEW 2. GOVERNANCE AND COMPLIANCE COMMITTEE CHARTER 3. COMPLIANCE COMMITTEE MEMBERSHIP CRITERIA 4. PAF ORGANIZATIONAL CODE OF CONDUCT 5. CONFLICTS OF INTEREST POLICY AND PROCEDURE FOR OFFICERS, EMPLOYEES, SUBCONTRACTORS AND AGENTS 6. POLICY ON DEVELOPMENT OF ANNUAL AUDITING AND MONITORING WORK PLAN 7. COMPLIANCE REPORTING AND NON-RETALIATION POLICY AND PROCEDURE 8. BACKGROUND CHECK POLICY 9. STAFF AND BOARD OF DIRECTORS COMPLIANCE TRAINING 10. ESTABLISHMENT OF AN ANONYMOUS HOTLINE FOR EMPLOYEES TO REPORT CONCERNS ANNUAL COMPLIANCE TRAINING WAS DELIVERED TO THE PAF EXECUTIVE BOARD OF DIRECTORS IN NOVEMBER 2017 AND THE ENTIRE PAF STAFF RECEIVED THE ANNUAL TRAINING IN AUGUST 2017. THESE TRAININGS INCLUDED A CLEAR OVERVIEW OF THE AKS AND CIVIL MONETARY PENALTIES LAW AND THEIR APPLICABILITY TO PAF AND THE CPR PROGRAM. ALL NEW HIRES, INCLUDING TEMPORARY STAFF, RECEIVE THE TRAINING DURING THE FIRST TWO DAYS OF EMPLOYMENT. ANNUAL REFRESHER TRAINING IS DELIVERED TO ALL STAFF, AND BOARD MEMBERS, AS WELL. FINALLY, TO ENSURE COMPLIANT COMMUNICATIONS WITH DONORS AND CLEARLY ARTICULATE PAF'S INDEPENDENCE OF OPERATIONS, PAF, IN COLLABORATION WITH THE PAF COMPLIANCE COUNSEL, DEVELOPED AND IMPLEMENTED DONOR COMMUNICATION, FUND DEVELOPMENT AND MANAGEMENT STANDARD OPERATING PROCEDURES AND ACCOMPANYING TEMPLATES. THIS MANUAL, AND ASSOCIATED MANDATORY TRAINING THAT IS DELIVERED ANNUALLY, PROVIDES GUIDELINES AND PROCEDURES RELATIVE TO KEY AREAS OF DONOR INTERACTION &amp; OPERATIONAL DESIGN DECISIONS. 2. SOURCES OF SUPPORT PAF HAS BEEN SUCCESSFUL IN PROCURING SUBSTANTIAL CHARITABLE CONTRIBUTIONS FROM A DIVERSITY OF SOURCES INCLUDING THE GENERAL PUBLIC, GOVERNMENTAL AGENCIES, OTHER 501(C) 3 PUBLIC CHARITIES, RESEARCH &amp; ACADEMIC INSTITUTIONS, PRIVATE FOUNDATIONS AND CORPORATE DONORS. OVER THE PAST 5 YEARS, PAF HAS RECEIVED GRANTS, COOPERATIVE AGREEMENTS AND/OR CHARITABLE CONTRIBUTIONS FROM ORGANIZATIONS INCLUDING, BUT NOT LIMITED TO, THE FOLLOWING: OTHER 501(C)3 CHARITABLE ORGANIZATIONS INCLUDE: O ALLIANCE FOR AGING RESEARCH O AMERICAN CANCER SOCIETY O APLASTIC ANEMIA &amp; MDS INTERNATIONAL FOUNDATION O ALS ASSOCIATION O AVON PRODUCTS FOUNDATION, INC. O AVON BREAST CANCER CRUSADE, LLC O BREAST CANCER AWARENESS COMMITTEE (CA) O CAN DO MULTIPLE SCLEROSIS O COMMUNITY ONCOLOGY ALLIANCE O THE DONNA FOUNDATION O FRIENDS OF CANCER RESEARCH O GOODCOIN FOUNDATION O GUIDESTAR.ORG O IOWA CANCER CONSORTIUM O JPMORGAN CHASE FOUNDATION O LEUKEMIA AND LYMPHOMA SOCIETY O LIBERTY HILL BAPTIST CHURCH O LIVESTRONG FOUNDATION O LUNGEVITY FOUNDATION O NATIONAL COMPREHENSIVE CANCER NETWORK, INC. O ONCOLOGY NURSING SOCIETY, LANCASTER RED ROSE CHAPTER O ORANGE COUNTY'S UNITED WAY O PANCREATIC CANCER ACTION NETWORK O PHRMA FOUNDATION O SCHWAB CHARITABLE O SILICON VALLEY COMMUNITY FOUNDATION O SUSAN G. KOMEN FOR THE CURE O TIAA CHARITABLE INC. O UNITED WAY SALT LAKE O THE WISHLIST FOUNDATION O ZERO-THE END OF PROSTATE CANCER GOVERNMENTAL AGENCIES: O CENTER FOR DISEASE CONTROL (4, MULTI-YEAR COOPERATIVE AGREEMENTS) O NATIONAL CANCER INSTITUTE (NCI) CORPORATIONS AND CORPORATE FOUNDATIONS O INCREASED CORPORATE PARTNERS FROM: 17 IN FY2011/2012 30 IN FY2015/2016 71 IN FY2016/2017 88 IN FY2017/2018 ACADEMIC AND RESEARCH INSTITUTIONS &amp; PRIVATE FOUNDATIONS O BEGIN AGAIN FOUNDATION O DUKE UNIVERSITY O ECOG-ACRIN MEDICAL RESEARCH FOUNDATION O FRED HUTCHINSON CANCER RESEARCH CENTER O HIGH PINES FOUNDATION O JEFF GORDON CHILDREN'S FOUNDATION O JENNIFER JAFF CENTER O KINGS CARE FOUNDATION O MAHAN FOUNDATION O OBICI HEALTHCARE FOUNDATION O RIVERSIDE HEALTH SYSTEM FOUNDATION O ROBERT WOOD JOHNSON FOUNDATION O SEATTLE CANCER CARE ALLIANCE O THE WILDFLOWER FOUNDATION O VITOLOGY FOUNDATION GENERAL PUBLIC O RECEIVED MEMORIAL, HONORARY AND GENERAL SUPPORT AND CONTRIBUTIONS FROM OVER 650 INDIVIDUALS IN FY2017/2018, A 31% INCREASE OVER THE PREVIOUS FISCAL YEAR. O HOSTED BLACK TIE GALA IN FEBRUARY 2018 ATTENDED BY OVER 300 GUESTS SUPPORTING THE EVENT, INCLUDING LIVE AND SILENT AUCTION O RECEIVED SUPPORT FROM MORE THAN 70 INDIVIDUAL DONORS AND 4 CORPORATE DONORS IN SUPPORT OF STAFF PARTICIPATION IN CRAWL N' CRAB 5K RACE IN 2018, A 40% INCREASE IN INDIVIDUAL DONORS OVER THE PREVIOUS FISCAL YEAR. O RECEIVED DONATIONS FROM OVER 1800 INDIVIDUALS OVER THE PAST 5 YEARS IN FY2017/2018, PAF RECEIVED CONTRIBUTIONS FROM OVER 750 DONORS INCLUDING SUPPORT FROM INDIVIDUALS, CORPORATE PARTNERS AND FOUNDATIONS, GOVERNMENT AGENCIES AND NON-PROFIT ORGANIZATIONS. 3. REPRESENTATIVE GOVERNING BODY THE PAF EXECUTIVE BOARD OF DIRECTORS COMPRISED OF 16 MEMBERS, ALL OF WHOM ARE NATIONALLY RECOGNIZED EXPERTS IN THE FIELDS OF HEALTHCARE ADMINISTRATION, CLINICAL PRACTICE AND RESEARCH, DIRECT PATIENT CARE, NON-PROFIT MANAGEMENT, GOVERNMENT/PUBLIC HEALTH, PATIENT ADVOCACY, HEALTH INSURANCE, TECHNOLOGY AND LAW. THE COMPOSITION OF THE BOARD IS A LIVING DEMONSTRATION TO PAF'S COMMITMENT REPRESENTING THE BROAD INTEREST, AND UNIQUE PERSPECTIVES, OF THE GENERAL PUBLIC AND TO GOVERN THE OPERATIONS WITH A DIVERSE, YET UNIFIED, POINT OF VIEW THAT WILL ENABLE THE FOUNDATION TO EXECUTE MEANINGFUL PATIENT PROGRAMS, DESIGNED TO ADDRESS GAPS IN THE CURRENT HEALTHCARE ENVIRONMENT AND ATTRACT SUPPORT FROM A BROAD RANGE OF POTENTIAL DONORS. THE PAF EXECUTIVE BOARD OF DIRECTORS HOLDS FIDUCIARY RESPONSIBILITY AND MANAGES AND CONTROLS THE ORGANIZATION AND PROPERTY OF PAF TO THE EXTENT VESTED IN THEM BY THE PAF BYLAWS. IT IS THE RESPONSIBILITY OF THE BOARD TO INSURE THE ORGANIZATION IS RUN IN A FISCALLY RESPONSIBLE MANNER AND THAT ALL PROGRAMS INITIATED AND DELIVERED BY PAF ARE GERMANE TO THE MISSION OF PAF. THE PAF BOARD OF DIRECTORS ASSESSES THE ORGANIZATIONS PERFORMANCE AND EFFECTIVENESS AND DETERMINES FUTURE ACTIONS REQUIRED, IF ANY, TO ACHIEVE ITS MISSION. THE BOARD OF DIRECTORS STRUCTURE ALSO HAS SEVEN (7) SUBCOMMITTEES THAT INCLUDE: EXECUTIVE COMMITTEE, GOVERNANCE &amp; COMPLIANCE COMMITTEE, FINANCE &amp; AUDIT COMMITTEE, COMPENSATION AND BENEFITS COMMITTEE, PROGRAM COMMITTEE, DEVELOPMENT/NOMINATING COMMITTEE AND BUILDING AND GROUNDS COMMITTEE. THE FULL BOARD OF DIRECTORS MEETS THREE (3) TIMES PER YEAR, TWICE IN PERSON AND ONCE VIA CONFERENCE CALL TO BE BRIEFED ON THE ACTIVITIES OF THE FOUNDATION INCLUDING PROGRAM INITIATIVES AND OUTCOMES, FINANCIALS AND OVERALL ORGANIZATIONAL GROWTH AND FUNCTIONALITY. THE FULL BOARD IS ALSO SUPPLIED WITH SUPPLEMENTAL ORGANIZATIONAL IMPACT REPORTS TWICE PER YEAR AS WELL AS THE ANNUAL IMPACT REPORT, WHICH IS ALSO MADE PUBLICLY AVAILABLE. THE FINANCE COMMITTEE IS SUPPLIED WITH FINANCIAL REPORTS ON A REGULAR BASIS FOR REVIEW AND COMMENT AND THE FULL EXECUTIVE BOARD RECEIVES A FULL FINANCIAL REPORTING PACKAGE ON A BIANNUAL BASIS. THE PAF EXECUTIVE BOARD IS A VERY KNOWLEDGEABLE ABOUT THE HEALTHCARE AND BUSINESS ENVIRONMENTS AND SERVES AS ADVISORS TO PAF MANAGEMENT TO ENSURE THAT PAF PROGRAMMING IS MEETING THE NEEDS OF THE CHRONICALLY AND CRITICALLY ILL PATIENTS LIVING AMONG US IN THE GENERAL POPULATION. PAF'S COMPLIANCE PROGRAM REQUIRES THAT ALL BOARD OF DIRECTORS MEMBERS AGREE TO COMPLY WITH THE FOUNDATION'S CONFLICT OF INTEREST POLICY (COI), REQUIRING ANNUAL DISCLOSURE OF ANY REAL OR POTENTIAL CONFLICTS, AS WELL AS DISCLOSURE THROUGHOUT THE YEAR IF NEW REAL OR POTENTIAL CONFLICTS ARISE THROUGH THE COMPLETION OF THE COI DISCLOSURE FORM. FURTHER, ALL DIRECTORS AGREE TO COMPLETE FORM 990 DIRECTOR AND OFFICER DISCLOSURE STATEMENT, REQUIRING THE ANNUAL EVALUATION OF THE DIRECTOR'S INDEPENDENCE PURSUANT TO IRS REQUIREMENTS AND DEFINITION OF "INDEPENDENCE". PURSUANT TO THESE STANDARDS, PAF HAD 13 INDEPENDENT DIRECTORS IN FY2017/2018 AND THREE DIRECTORS WHO WERE NON-INDEPENDENT, INCLUSIVE OF THE CURRENT CEO, AND THE TWO FOUNDERS OF THE ORGANIZATION. CONTINUED LATER IN SCHEDULE O (E).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCH A, PART II, SECTION C, LINE 17A, FACTS A</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUATION FROM SCHEDULE O (E). PAF'S GOVERNANCE AND COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS IS CHARGED WITH OVERSEEING, MONITORING, AND ENFORCING COMPLIANCE WITH BOARD STANDARDS OF CONDUCT AND DUTIES, INCLUDING, BUT NOT LIMITED TO COI, SELF-DEALING, CODE OF CONDUCT, CONFIDENTIALITY, AND COMPENSATION. THEY ARE CHARGED WITH THE REVIEW AND DETERMINATIONS OF COI'S AND DIRECTOR'S INDEPENDENCE ANNUALLY AND, AS REQUIRED. MEMBERS OF THE COMMITTEE ARE SUBJECT TO THE INDEPENDENCE POLICY AND MUST MEET ALL THREE CRITERIA UNDER THE IRS INDEPENDENCE TEST. FURTHER, THE DIRECTOR, NOR IMMEDIATE FAMILY MEMBER OF THE DIRECTOR, CAN BE A DONOR TO PAF'S CPR PROGRAM OR A DIRECTOR, OFFICER OR EMPLOYEE OF A DONOR TO PAF'S CPR PROGRAM. A DIRECTOR CANNOT BE A FORMER DIRECTOR, OFFICER OR EMPLOYEE OF A DONOR TO PAF'S CPR PROGRAM MAINTAINING AN ONGOING RELATIONSHIP WITH SUCH DONOR (VIA CONSULTING OR OTHERWISE). A DIRECTOR CANNOT BE AN IMMEDIATE FAMILY MEMBER OR FORMER DIRECTOR, OFFICER OR EMPLOYEE OF A DONOR TO PAF'S CPR PROGRAM AND SUCH IMMEDIATE FAMILY MEMBER MAINTAINS AN ONGOING RELATIONSHIP WITH SUCH DONOR (VIA CONSULTING OR OTHERWISE). THE COMMITTEE IN FY2017/2018 CONSISTED OF SIX (6) INDEPENDENT MEMBERS OF THE PAF BOARD OF DIRECTORS. PAF'S BOARD DOES NOT INCLUDE ANY EMPLOYEE AND/OR BOARD MEMBERS OF A DONOR ORGANIZATION, THUS, ELIMINATING THE INFLUENCE OF A DONOR FROM THE GOVERNING BODY OF PAF. MOREOVER, NO DONOR HAS THE AUTHORITY TO APPOINT DIRECTORS TO THE PAF BOARD. IN THIS REGARD, PAF IS STRIKINGLY DIFFERENT FROM A PRIVATE FOUNDATION WHERE IT IS COMMONPLACE FOR THE GOVERNING BODY TO BE COMPRISED OF MAJOR CONTRIBUTORS, MEMBERS CHOSEN BY MAJOR CONTRIBUTORS AND/OR FAMILY MEMBERS AFFILIATED TO THE FOUNDATION, OR BOTH. 4. AVAILABILITY OF PUBLIC FACILITIES OR SERVICES; PUBLIC PARTICIPATION IN PROGRAMS OR POLICIES PAF'S PROGRAMS ARE DESIGNED FOR, AND AVAILABLE TO, THE GENERAL PUBLIC AND THE ORGANIZATION'S OPERATIONAL MODELS SUPPORT BROAD AVAILABILITY OF AND ACCESS TO PAF'S PATIENT SERVICES INCLUDING CASE MANAGEMENT SUPPORT, FINANCIAL AID FUNDS, THE CO-PAY RELIEF PROGRAM, PATIENT EDUCATION AND EMPOWERMENT PROGRAMS AND HEALTH EQUITY PROGRAMMING. OVER THE COURSE OF THE ORGANIZATION'S HISTORY, PAF HAS CONTINUOUSLY OFFERED PATIENT SERVICE PROGRAMS TO THE PUBLIC. THERE HAS BEEN A GREAT DEAL OF TIME AND ENERGY DEDICATED TO THE PROMOTION OF THE PROGRAMS OFFERED BY PAF AS IT IS A KEY PRIORITY OF THE ORGANIZATION THAT THE PROGRAMS REACH ANYONE WHO NEEDS THEM. IN FY2017/2018, PAF SERVED NEARLY 144,000 PEOPLE, LIVING IN ALL 50 STATES AND US TERRITORIES, SUFFERING WITH 490 VARIOUS CHRONIC, DEBILITATING AND/OR CRITICAL DISEASES. REFERRALS INTO PAF PROGRAMS COME FROM THOUSANDS OF SOURCES, WITH OTHER CHARITABLE NON-PROFIT ORGANIZATIONS TOPPING THE LIST WITH THE GREATEST FREQUENCY OF REFERRALS, AS DOCUMENTED IN THE PAF PATIENT PROGRAM DATABASES. EACH PATIENT SERVED BY PAF NEEDED ASSISTANCE WITH ACCESS TO CARE AND AFFORDABILITY ISSUES, INCLUDING COST OF LIVING CHALLENGES THAT THEY FACED DUE TO THEIR ILLNESS. PATIENTS ARE EDUCATED ABOUT THE AVAILABILITY OF THE PAF PROGRAMS THROUGH MANY CHANNELS INCLUDING, BUT NOT LIMITED TO, MEDIA (EARNED AND PAID), OTHER NON-PROFIT, DISEASE SPECIFIC ORGANIZATIONS, PROVIDERS, PHARMACIES, SOCIAL WORKERS, FINANCIAL COUNSELORS, SOCIAL SERVICES, GOVERNMENT AGENCIES AND OTHER PATIENTS SERVED PREVIOUSLY BY PAF. PAF UTILIZES VARIOUS PROMOTIONS AND EDUCATION ACTIVATES TO ENSURE THAT THERE IS BROAD AWARENESS IN THE GENERAL PUBLIC, AND AMONG THOSE HEALTHCARE STAKEHOLDERS CARING FOR THE SICK AND DISABLED LIVING IN SOCIETY, OF THE FOUNDATION'S PATIENT PROGRAMS INCLUDING, BUT NOT LIMITED TO: REGULAR EMAIL COMMUNICATIONS TO THE PAF LIST SERVE; INCLUSIVE OF THOUSANDS OF PROVIDERS, PHARMACIES, NON-PROFIT ORGANIZATIONS, PATIENTS, FAMILIES AND CAREGIVERS WHO HAVE UTILIZED PAF PROGRAMS DEVELOPMENT AND MAINTENANCE OF PAF AND CPR WEBSITES; INCLUSIVE OF EXTENSIVE PATIENT EDUCATION MATERIALS AND RESOURCE DIRECTORIES/ONLINE TOOLS. ROUTINE PARTICIPATION IN LOCAL, REGIONAL AND NATIONAL OUTREACH EVENTS; INCLUDING EXHIBITING AT CONFERENCES, SPEAKING ENGAGEMENTS, AND TRAINING SESSIONS FOR OTHER AGENCIES. ROUTINE DELIVERY OF "PATIENT EMPOWERMENT SERIES", AN EDUCATIONAL WEBINAR SERIES DESIGNED TO TEACH THE FUNDAMENTAL CONCEPTS OF VARIOUS HEALTHCARE/INSURANCE AND/OR ENTITLEMENT PROGRAMS; LIVE AND ON DEMAND LINKS FROM AND TO VARIOUS NON-PROFIT PATIENT ORGANIZATIONS WEBSITES AND PAF'S WEBSITES AND ONLINE RESOURCE TOOLS. ONGOING RELATIONSHIP DEVELOPMENT AND MAINTENANCE WITH DISEASE SPECIFIC NON-PROFIT ORGANIZATIONS THAT SERVE THE PATIENTS FOR WHICH WE HAVE PROGRAMS AVAILABLE TO ENSURE THEY ARE CONNECTING PATIENTS TO OUR PROGRAMS AS THEY NEED OUR SUPPORT. DISTRIBUTION OF PRESS RELEASES PUBLICLY ANNOUNCING THE ADDITION OF NEW PATIENT PROGRAMS AND/OR EXPANSION OF EXISTING PROGRAMS. INCLUSION IN EARNED MEDIA STORIES; PROFILES OF PAF PROGRAMS AND PATIENTS SERVED BY PAF SUMMARY IN SUMMARY, PATIENT ADVOCATE FOUNDATION EMBODIES ALL THE CHARACTERISTICS OF A PUBLICLY SUPPORTED ORGANIZATION, BASED ON THE FACTS AND CIRCUMSTANCES TEST DESCRIBED IN SECTION 1.170A-9(E) (3) OF THE TREASURY REGULATIONS. PAF DEMONSTRATES, IN POLICY AND PRACTICE, THAT ITS OPERATIONS ARE FREE FROM THE INFLUENCE AND CONTROL OF ITS DONORS, FURTHER, THERE IS NO EVIDENCE THAT A SMALL GROUP OF DONORS CONTROL PAF; RATHER, PAF IS A DIVERSE, COMPLEX PATIENT SUPPORT ORGANIZATION THAT HAS OPERATED AS A PUBLICLY SUPPORTED ORGANIZATION, MEETING THE ONE-THIRD TEST FOR MOST OF ITS 22-YEAR HISTORY. PAF CONTINUES TO OPERATE CONGRUENTLY WITH A PUBLICLY SUPPORTED ORGANIZATION, INCLUDING GARNERING SUPPORT FROM A BROAD CROSS SECTION OF DONORS, INCLUDING THE GOVERNMENT, OTHER PUBLIC CHARITIES AND THE GENERAL PUBLIC, WITH A REPRESENTATIVE GOVERNING BODY. PAF CONTINUES ITS DILIGENCE IN SEEKING NEW SOURCES OF SUPPORT FROM THE GENERAL PUBLIC AS WELL AS OTHER ORGANIZATIONS AND GOVERNMENTAL AGENCIES. ACCORDINGLY, THE FOUNDATION QUALIFIES AS A "PUBLICLY SUPPORTED ORGANIZATION AS DESCRIBED IN SECTION 170(B) (1) (A) (VI).</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>NATIONAL PATIENT ADVOCATE FOUNDATION (NPAF)</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>725 15TH STREET</AddressLine1Txt>
          <CityNm>WASHINGTON</CityNm>
          <StateAbbreviationCd>DC</StateAbbreviationCd>
          <ZIPCd>20005</ZIPCd>
        </USAddress>
        <EIN>541839226</EIN>
        <PrimaryActivitiesTxt>SEEKS TO REMOVE OBSTACLES TO HEALTHCARE ACCESS FOR PATIENTS</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>VA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(4)</ExemptCodeSectionTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NPAF IS THE SISTER ORGANIZATION TO PAF MRBALCH IS CEO OF AND PAID BY BOTH</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>0</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>1</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>0</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>0</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>1</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>1</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>1</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>1</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>1</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>1</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>0</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>0</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>NATIONAL PATIENT ADVOCATE FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>B</TransactionTypeTxt>
        <InvolvedAmt>45000</InvolvedAmt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>NATIONAL PATIENT ADVOCATE FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>M</TransactionTypeTxt>
        <InvolvedAmt>780000</InvolvedAmt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>NATIONAL PATIENT ADVOCATE FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>362200</InvolvedAmt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>NATIONAL PATIENT ADVOCATE FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>P</TransactionTypeTxt>
        <InvolvedAmt>5562</InvolvedAmt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>NATIONAL PATIENT ADVOCATE FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>6448</InvolvedAmt>
      </TransactionsRelatedOrgGrp>
    </IRS990ScheduleR>
  </ReturnData>
</Return>